{"doc_id": 0, "doc": {"person_id": 115967699, "visit_occurrence_id": 172123964, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-01-26 00:00:00", "visit_end_datetime": "2021-01-26 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n", "approximate_token_count": 130, "patient_first_visit_date": "2018-07-27 08:09:53", "patient_last_visit_date": "2022-11-11 10:16:14", "end_obs_date": "2022-01-26", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 38, "cumulated_visit_num": 38, "cumulated_approximate_token_count": 5226, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2018-07-27 08:09:53, ended at 2018-07-27 09:18:56\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low grade squamous intraepithelial lesion on cervical Papanicolaou smear\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-27, presumably until 2019-02-15, with intended 1 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) every bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 15.6 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 265.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 41.3 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 15:14:21, ended at 2019-02-15 15:46:51\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-15, presumably until 2019-02-20, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-20, presumably until 2019-03-01, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-03-01, presumably until 2019-03-07, with intended 1 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-05-30, presumably until 2019-10-18, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER SKIN EVERY EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-28 00:00:00, ended at 2019-08-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-04 00:00:00, ended at 2019-09-04 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-06 11:31:00, ended at 2019-09-06 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation on X-ray examination made elsewhere, written report\n\n### Condition\n- Mammographic calcification of breast\n- Mammographic microcalcification of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-12 12:25:00, ended at 2019-09-12 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in upper inner quadrant of right breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-12, presumably until 2019-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-09-24, presumably until 2019-11-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-11-07, presumably until 2020-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-01-08, presumably until 2020-02-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-07, presumably until 2020-01-21, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER THE SKIN EVERY EVENING\n- atorvastatin 40 MG Oral Tablet, started on 2020-01-07, presumably until 2020-07-13, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 15:09:17, ended at 2020-01-21 15:59:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.0 (percent)\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Essential hypertension\n- Mild nonproliferative retinopathy of left eye due to diabetes mellitus\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-05-20, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-21, presumably until 2020-01-28, with intended 3 refill(s). Instructions: 24 Units by abdominal subcutaneous route AM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-02-04, presumably until 2020-02-04, with intended 1 refill(s). Instructions: inject 100 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-02-28, presumably until 2020-04-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-04-13, presumably until 2020-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-07-13, presumably until 2021-01-16, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-06 20:40:00, ended at 2020-10-06 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-30 11:10:00, ended at 2020-10-30 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-12 00:00:00, ended at 2020-11-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Lump in upper inner quadrant of right breast\n- Lump in upper outer quadrant of right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-11-12, presumably until 2020-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-13 12:00:00, ended at 2020-11-13 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 07:03:00, ended at 2020-12-02 09:27:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 09:28:00, ended at 2020-12-02 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Disorder of breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-09 15:16:28, ended at 2020-12-09 15:58:22\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including ultrasound guidance\n\n### Condition\n- Benign neoplasm of right breast\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-12-31 00:00:00, ended at 2020-12-31 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2020-12-31, presumably until 2020-12-31\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-12-31, presumably until 2020-12-31\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2020-12-31, presumably until 2020-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-01-16, presumably until 2022-02-18, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-07-27 08:09:53, ended at 2018-07-27 09:18:56\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low grade squamous intraepithelial lesion on cervical Papanicolaou smear\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-27, presumably until 2019-02-15, with intended 1 refill(s). Instructions: inject 10 Units subcutaneous (under the skin) every bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2018-07-27, presumably until 2019-03-07, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-22 00:00:00, ended at 2018-12-22 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Creatinine [Mass Ratio] in Urine: 15.6 (milligram per gram of creatinine)\n- Creatinine [Mass/volume] in Urine: 265.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 41.3 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 57 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-15 15:14:21, ended at 2019-02-15 15:46:51\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-15, presumably until 2019-02-20, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-20 00:00:00, ended at 2019-02-20 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 300 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-02-20, presumably until 2019-03-01, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin degludec 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2019-03-01, presumably until 2019-03-07, with intended 1 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-05-30 00:00:00, ended at 2019-05-30 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-05-30, presumably until 2019-10-18, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER SKIN EVERY EVENING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-28 00:00:00, ended at 2019-08-28 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-04 00:00:00, ended at 2019-09-04 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-06 11:31:00, ended at 2019-09-06 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation on X-ray examination made elsewhere, written report\n\n### Condition\n- Mammographic calcification of breast\n- Mammographic microcalcification of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-12 12:25:00, ended at 2019-09-12 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in upper inner quadrant of right breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-09-12, presumably until 2019-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-23 00:00:00, ended at 2019-09-23 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-09-24, presumably until 2019-11-06, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-26 00:00:00, ended at 2019-09-26 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-06 00:00:00, ended at 2019-11-06 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2019-11-07, presumably until 2020-01-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-01-08, presumably until 2020-02-28, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-07, presumably until 2020-01-21, with intended 3 refill(s). Instructions: INJECT 15 UNITS UNDER THE SKIN EVERY EVENING\n- atorvastatin 40 MG Oral Tablet, started on 2020-01-07, presumably until 2020-07-13, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-21 15:09:17, ended at 2020-01-21 15:59:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.0 (percent)\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperlipidemia\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus\n- Primary diagnosis: Essential hypertension\n- Mild nonproliferative retinopathy of left eye due to diabetes mellitus\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2020-05-20, with intended 3 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-01-21, presumably until 2020-01-28, with intended 3 refill(s). Instructions: 24 Units by abdominal subcutaneous route AM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-04 00:00:00, ended at 2020-02-04 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-02-04, presumably until 2020-02-04, with intended 1 refill(s). Instructions: inject 100 Units subcutaneous (under the skin) daily in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-02-28, presumably until 2020-04-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2020-04-13, presumably until 2020-05-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-12 00:00:00, ended at 2020-07-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-07-13, presumably until 2021-01-16, with intended 1 refill(s). Instructions: TAKE 1 TABLET(40 MG) BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-21 00:00:00, ended at 2020-09-21 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-06 20:40:00, ended at 2020-10-06 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-08 00:00:00, ended at 2020-10-08 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-30 11:10:00, ended at 2020-10-30 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-12 00:00:00, ended at 2020-11-12 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including ultrasound guidance\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Lump in upper inner quadrant of right breast\n- Lump in upper outer quadrant of right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-11-12, presumably until 2020-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-12 08:36:00, ended at 2020-11-12 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-13 12:00:00, ended at 2020-11-13 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred material requiring preparation of slides\n- Morphometric analysis, tumor\n\n### Condition\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 07:03:00, ended at 2020-12-02 09:27:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including magnetic resonance guidance\n\n### Condition\n- Abnormal findings on diagnostic imaging of breast\n- Lump in right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-02 09:28:00, ended at 2020-12-02 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Disorder of breast\n- Abnormal findings on diagnostic imaging of breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-09 15:16:28, ended at 2020-12-09 15:58:22\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Placement of breast localization device(s) (eg, clip, metallic pellet, wire/needle, radioactive seeds), percutaneous; first lesion, including ultrasound guidance\n\n### Condition\n- Benign neoplasm of right breast\n- Neoplasm of uncertain behavior of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-29 15:00:00, ended at 2020-12-29 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic mammography, including computer-aided detection (CAD) when performed; unilateral\n\n### Condition\n- Lump in right breast\n- Benign neoplasm of right breast\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-12-31 00:00:00, ended at 2020-12-31 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2020-12-31, presumably until 2020-12-31\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2020-12-31, presumably until 2020-12-31\n- 10 ML bupivacaine hydrochloride 2.5 MG/ML Injection, started on 2020-12-31, presumably until 2020-12-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-01-16, presumably until 2022-02-18, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- metformin hydrochloride 1000 MG Oral Tablet, started on 2021-01-27, presumably until 2021-11-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET(1000 MG) BY MOUTH TWICE DAILY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "1668150d2b3e770bfb3911310bd351686f588bb3374f134c775b7773e328fad2", "prompt_hash": "b5c0ece08fa598497708bb7fe3ed7c58db210e1b8c650d672b7fe8edd06423ca", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 1, "doc": {"person_id": 115967769, "visit_occurrence_id": 159320772, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2020-05-17 00:00:00", "visit_end_datetime": "2020-05-17 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n", "approximate_token_count": 123, "patient_first_visit_date": "2012-03-31 14:46:00", "patient_last_visit_date": "2023-02-06 10:56:09", "end_obs_date": "2021-05-17", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 129, "cumulated_visit_num": 129, "cumulated_approximate_token_count": 24713, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-03-31 14:46:00, ended at 2012-03-31 16:19:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.34 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Insertion of non-indwelling bladder catheter (eg, straight catheterization for residual urine)\n\n### Condition\n- Chronic pain\n- Dysuria\n- Abdominal pain\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus without complication\n- Congestive heart failure\n- Type 1 diabetes mellitus uncontrolled\n- Chronic kidney disease\n- Chronic obstructive lung disease\n- Neurogenic bladder\n- Nausea\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-20 00:00:00, ended at 2018-10-20 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-05 12:36:05, ended at 2019-01-05 15:56:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.228\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Coronary artery graft present\n- Mixed hyperlipidemia\n- Nicotine dependence\n- Old myocardial infarction\n- Pulmonary emphysema\n- Renal disorder due to type 1 diabetes mellitus\n- Bilateral hearing loss\n- Anemia in chronic kidney disease\n- Chronic nephritic syndrome\n- End-stage renal disease\n- Essential hypertension\n- Vitamin D deficiency\n- Hyperparathyroidism due to renal insufficiency\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-01-05 15:58:00, ended at 2019-01-05 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C peptide [Mass/volume] in Serum or Plasma: <0.02 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-01-12 00:00:00, ended at 2019-01-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 00:00:00, ended at 2019-02-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-02-23 08:37:00, ended at 2019-02-23 13:35:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 14.62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 251 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.41 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 89 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Primary diagnosis: Hearing loss of right ear\n- Atelectasis\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic pain\n- Obesity\n- Type 2 diabetes mellitus\n- Bilateral hearing loss\n- Heart failure\n- Atherosclerosis of coronary artery without angina pectoris\n- Chronic obstructive lung disease\n- Sudden hearing loss\n- Disorder of bronchus\n- Hypertensive heart and chronic kidney disease\n- Disorder of nervous system due to type 2 diabetes mellitus\n- End-stage renal disease\n- Hearing loss of left ear\n\n### Drug\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-03-05, with intended 0 refill(s). Instructions: take 1.5 Tabs (600 mg total) by mouth daily for 10 days\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-02-23, presumably until 2019-04-15, with intended 1 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily for 60 doses Take 6 tabs (60mg) daily for 3 days, then 5 tabs daily for 3 days, then 4 tabs daily for 3 days, then 3 tabs daily for 2 days, then 2 tabs daily for 2 days, then 1 tab daily for 2 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-24 07:30:51, ended at 2019-02-24 12:44:18\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Labyrinthotomy, with perfusion of vestibuloactive drug(s), transcanal\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sudden hearing loss\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 200 mg by mouth\n- atorvastatin 10 MG Oral Tablet, started on 2018-12-19, presumably until 2019-04-15, with intended 0 refill(s)\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-01-14, presumably until 2019-04-15, with intended 0 refill(s)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2018-12-12, presumably until 2019-04-15, with intended 0 refill(s). Instructions: take 81 mg by mouth\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2019-02-19, presumably until 2019-04-15, with intended 0 refill(s)\n- losartan potassium 100 MG Oral Tablet, started on 2019-02-17, presumably until 2019-04-15, with intended 0 refill(s)\n- furosemide 80 MG Oral Tablet, started on 2018-12-21, presumably until 2019-04-15, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-24 07:31:03, ended at 2019-02-24 08:47:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tympanometry (impedance testing)\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Sudden hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-03 09:57:52, ended at 2019-03-03 11:50:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-03 09:58:03, ended at 2019-03-03 11:50:40\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-08 07:24:30, ended at 2019-03-08 09:43:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-08 07:24:41, ended at 2019-03-08 08:42:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-09 07:17:57, ended at 2019-03-09 09:04:26\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-12 00:00:00, ended at 2019-03-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-23 08:42:00, ended at 2019-03-23 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Interstitial lung disease\n- Abnormal findings on diagnostic imaging of lung\n- Fibrosis of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-24 07:21:38, ended at 2019-03-24 10:09:25\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pure tone audiometry (threshold); air only\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Tympanometry (impedance testing)\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-03-24 07:21:55, ended at 2019-03-24 12:22:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 12:57:53, ended at 2019-03-26 15:17:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-03-26 16:52:00, ended at 2019-03-26 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Atherosclerosis of aorta\n- Sensorineural hearing loss, bilateral\n- Opioid dependence in remission\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-15 11:55:31, ended at 2019-04-15 16:21:50\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Complication due to diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Retinal disorder\n- Type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Mixed conductive AND sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n- Chronic obstructive lung disease\n- Disorder of upper gastrointestinal tract\n- Heart failure\n- End-stage renal disease\n- Illness\n- Bipolar disorder in remission\n- Chronic pain\n- Pure hypercholesterolemia\n- Dependence on supplemental oxygen\n- Mechanical complication of peritoneal dialysis catheter\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-15 16:14:08, ended at 2019-04-15 17:19:35\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.346\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: End-stage renal disease\n- Retinal disorder\n- Complication due to diabetes mellitus\n- Pure hypercholesterolemia\n- Chronic pain\n- Mechanical complication of peritoneal dialysis catheter\n- Renal disorder due to type 1 diabetes mellitus\n- Bipolar disorder in remission\n- Dependence on supplemental oxygen\n- Chronic obstructive lung disease\n- Heart failure\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Disorder of upper gastrointestinal tract\n- Type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2019-11-22, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n- vitamin E, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- selenomethionine, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2019-06-07, with intended 11 refill(s). Instructions: take 1 Tab (50 mg total) by mouth daily\n- cholecalciferol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- folic acid, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- wheat germ oil, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- alpha tocopherol, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2019-07-07, with intended 1 refill(s). Instructions: place 1.5 Tabs under the tongue and let dissolve every day\n- zinc oxide, through Oral route, presumably until 2019-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2019-04-15, presumably until 2020-02-28, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-06, with intended 11 refill(s). Instructions: take 1 Tab (81 mg total) by mouth daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2019-04-15, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 18 units under the skin at bedtime\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-04-15, presumably until 2020-04-26, with intended 11 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2019-04-15, presumably until 2020-04-14, with intended 11 refill(s). Instructions: place 1 Tab (0.4 mg total) under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-19 14:07:51, ended at 2019-04-19 17:41:30\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 19 (millimeter mercury column)\n- Intraocular pressure of right eye: 17 (millimeter mercury column)\n\n### Procedure\n- Intravitreal injection of a pharmacologic agent (separate procedure)\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n- Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral\n\n### Condition\n- Primary diagnosis: Retinal neovascularization\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-20 12:25:18, ended at 2019-04-20 13:25:37\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Pulmonary hypertension\n- Severe nonproliferative retinopathy due to diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Nonproliferative diabetic retinopathy due to type 1 diabetes mellitus\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-04-20, presumably until 2019-05-04, with intended 5 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 14 days\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-20, presumably until 2019-04-26, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs (4-8 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 4 MG Oral Tablet, through Oral route, started on 2019-04-26, presumably until 2019-05-04, with intended 2 refill(s). Instructions: take 1 Tab (4 mg total) by mouth every 8 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-29 13:05:19, ended at 2019-04-29 15:15:57\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hearing loss\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2019-04-29, presumably until 2019-06-22, with intended 2 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 11:05:35, ended at 2019-05-04 13:44:21\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-04 13:34:13, ended at 2019-05-04 14:57:46\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take by mouth every day\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2019-12-06, with intended 0 refill(s). Instructions: take 12.5 mg by mouth every 6 hours as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-05 13:45:06, ended at 2019-05-05 15:08:22\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Type 1 diabetes mellitus\n- Pure hypercholesterolemia\n- Renal disorder due to type 1 diabetes mellitus\n- Sensorineural hearing loss\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Electrocardiogram abnormal\n- Primary diagnosis: Essential hypertension\n- Pulmonary emphysema\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 00:00:00, ended at 2019-05-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for procedures on lower anterior abdominal wall; not otherwise specified\n\n### Condition\n- Mechanical complication of peritoneal dialysis catheter\n- End-stage renal disease\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cefazolin 1000 MG Injection, started on 2019-05-07, presumably until 2019-05-07\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-07, presumably until 2019-05-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-07 07:10:00, ended at 2019-05-07 12:08:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Base excess in Arterial blood by calculation: 7.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.5 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 23.7 (millimeter mercury column)\n\n### Procedure\n- Removal of tunneled intraperitoneal catheter\n- Collection of venous blood by venipuncture\n- Removal of Infusion Device from Peritoneal Cavity, Open Approach\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: End-stage renal disease\n- Heart failure\n- Hypertensive heart and chronic kidney disease\n- Mechanical complication of peritoneal dialysis catheter\n- Hyperlipidemia\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-05-07, presumably until 2019-05-11, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-05-07, presumably until 2019-05-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-05-07, presumably until 2019-05-07\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-07, presumably until 2019-05-11, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-11 09:13:38, ended at 2019-05-11 13:20:07\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- cephalexin 250 MG Oral Capsule, through Oral route, started on 2019-05-11, presumably until 2019-05-16, with intended 0 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 4 times a day for 5 days\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2019-05-11, presumably until 2019-05-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-11 12:31:00, ended at 2019-05-11 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Disorder of brain\n- Hearing loss\n- Abnormal findings on diagnostic imaging of skull and head\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-18 10:33:23, ended at 2019-05-18 14:44:56\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-21 14:03:22, ended at 2019-05-21 15:43:17\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperglycemia due to type 1 diabetes mellitus\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n- Pulmonary hypertension\n- End-stage renal disease\n- Essential hypertension\n- Sensorineural hearing loss\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for procedures on external, middle, and inner ear including biopsy; not otherwise specified\n\n### Condition\n- Chronic kidney disease\n- Essential hypertension\n- Sensorineural hearing loss, bilateral\n- Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2019-05-27, presumably until 2019-05-27\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- ketamine 100 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 250 ML lidocaine hydrochloride 8 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- midazolam 1 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2019-05-27, presumably until 2019-05-27\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium hyaluronate 10 MG/ML Prefilled Syringe, through Intraocular route, started on 2019-05-27, presumably until 2019-05-27\n- epinephrine 0.01 MG/ML / lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-27 05:58:00, ended at 2019-05-27 12:20:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: 5.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 63.1 (millimeter mercury column)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Arterial blood: 27.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 31.4 (millimole per liter)\n- Body height: 5' 8\" (inch (US))\n- Oxygen [Partial pressure] in Arterial blood: 93.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Blood: 87 (milligram per deciliter)\n\n### Procedure\n- Cochlear device implantation, with or without mastoidectomy\n- Radiologic examination, skull; less than 4 views\n- Insertion of Single Channel Cochlear Prosthesis into Left Inner Ear, Open Approach\n\n### Condition\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Sarcoidosis\n- Heart failure\n- Old myocardial infarction\n- Retinopathy due to type 1 diabetes mellitus\n- Sensorineural hearing loss, bilateral\n- End-stage renal disease\n- Hypertensive heart and chronic kidney disease\n- Renal disorder due to type 1 diabetes mellitus\n- Uncomplicated asthma\n- Sensorineural hearing loss\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-05-27, presumably until 2019-06-26, with intended 0 refill(s). Instructions: take 1 Boley (10,000 Units total) by mouth daily\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2019-05-27, presumably until 2019-05-27\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-05-27, presumably until 2019-05-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2019-06-07, presumably until 2020-05-22, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-15 08:37:55, ended at 2019-06-15 10:25:51\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sensorineural hearing loss\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-15 08:38:27, ended at 2019-06-15 11:04:42\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; with programming\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-17 15:18:47, ended at 2019-06-17 16:25:29\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Dependence on supplemental oxygen\n- Leukocytosis\n- Sarcoidosis\n- Primary diagnosis: Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperglycemia due to type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Sensorineural hearing loss\n- End-stage renal disease\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-06-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, started on 2019-05-26, presumably until 2019-07-29, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-18 00:00:00, ended at 2019-06-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.41 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.6 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.18 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Leukocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-06-22 09:47:01, ended at 2019-06-22 10:28:28\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, presumably until 2019-07-29, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-06-22, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-22 13:45:04, ended at 2019-06-22 16:45:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-06-24 13:32:00, ended at 2019-06-24 23:59:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Sarcoidosis\n- Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-06 00:00:00, ended at 2019-07-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-07-06, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily 15 mg (3 x 5 mg) for 1 mo, 10 mg (2 x 5 mg) for 1 mo, 5 mg (1 x 5 mg) for 1 mo then STOP.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-07 00:00:00, ended at 2019-07-07 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-07-07, presumably until 2019-08-05, with intended 0 refill(s). Instructions: DISSOLVE 1&1/2 TABLETS UNDER TONGUE ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-12 11:41:00, ended at 2019-07-12 12:03:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Gas dilution or washout for determination of lung volumes and, when performed, distribution of ventilation and closing volumes\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Bronchodilation responsiveness, spirometry as in 94010, pre- and post-bronchodilator administration\n- Plethysmography for determination of lung volumes and, when performed, airway resistance\n\n### Condition\n- Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-13 11:35:08, ended at 2019-07-13 12:28:27\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-13 11:36:03, ended at 2019-07-13 15:03:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n- Comprehensive audiometry threshold evaluation and speech recognition (92553 and 92556 combined)\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-23 00:00:00, ended at 2019-07-23 12:10:45\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- vitamin E, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol 0.05 MG Oral Tablet, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 1 tablet by oral route once daily\n- selenomethionine, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cholecalciferol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- cefdinir 300 MG Oral Capsule, presumably until 2019-07-29, with intended 0 refill(s). Instructions: cefdinir 300 mg capsule\n- folic acid, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- ergocalciferol 1.25 MG Oral Capsule, started on 2014-03-15, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Take 1 capsule by mouth once a week for 10 weeks\n- wheat germ oil, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- alpha tocopherol, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- sucroferric oxyhydroxide 500 MG Chewable Tablet, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Velphoro 500 mg chewable tablet\n- zinc oxide, presumably until 2019-08-02, with intended 0 refill(s). Instructions: Take one tablet by mouth daily\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2012-08-06, presumably until 2019-07-29, with intended 0 refill(s). Instructions: Apply 1/2 patch to right foot, 1/2 patch to left foot once a day, may wear up to 12 hours.\n- 3 ML insulin aspart, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-09-28, presumably until 2019-11-23, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-29 12:02:28, ended at 2019-07-29 12:55:15\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Pulmonary hypertension\n- Chronic ulcer of foot\n- End-stage renal disease\n- Primary diagnosis: Type 1 diabetes mellitus\n\n### Drug\n- beta carotene 10000 UNT Oral Capsule, through Oral route, started on 2019-07-29, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Kravitz (10,000 Units total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-05, presumably until 2019-08-06, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-08-06 00:00:00, ended at 2019-08-06 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-08-06, presumably until 2019-09-17, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2019-08-23, presumably until 2019-10-06, with intended 3 refill(s). Instructions: by Topical route as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-24 00:00:00, ended at 2019-08-24 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- folic acid, through Oral route, started on 2019-08-24, presumably until 2019-10-06, with intended 3 refill(s). Instructions: take 1 Tab (0.8 mg total) by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:44:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-09-07 13:11:12, ended at 2019-09-07 15:59:48\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Pure tone audiometry (threshold); air only\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- amlodipine 5 MG Oral Tablet, started on 2019-09-09, presumably until 2019-09-21, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-24, presumably until 2019-09-24, with intended 0 refill(s). Instructions: DISSOLVE ONE AND ONE-HALF TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-17 00:00:00, ended at 2019-09-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n\n### Drug\n- naloxone hydrochloride 40 MG/ML Nasal Spray, started on 2019-09-17, presumably until 2021-10-13, with intended 1 refill(s). Instructions: Spray 0.1 mL (4 mg) into one nostril for suspected overdose. Repeat into other nostril after 2 to 3 minutes if no or minimal response.\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, through Sublingual route, started on 2019-09-17, presumably until 2019-10-17, with intended 0 refill(s). Instructions: place 2 Tabs under the tongue and let dissolve daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-22 00:00:00, ended at 2019-09-22 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet, started on 2019-09-23, presumably until 2019-09-23, with intended 0 refill(s). Instructions: Dissolve one and one half under the tongue daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:52:23, ended at 2019-09-28 18:06:19\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.583\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Atherosclerosis of coronary artery without angina pectoris\n- End-stage renal disease\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Essential hypertension\n- Nicotine dependence\n- Nondependent opioid abuse in remission\n- Primary diagnosis: Type 1 diabetes mellitus\n- Opioid abuse\n- Chronic ulcer of foot\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2019-09-28, presumably until 2019-09-28, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- varenicline 1 MG Oral Tablet, through Oral route, started on 2019-09-28, presumably until 2020-04-06, with intended 0 refill(s). Instructions: take 0.5 Tabs (0.5 mg total) by mouth 2 times a day Take daily for first 3 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-30 15:21:18, ended at 2019-09-30 16:33:16\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 20 (millimeter mercury column)\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina\n\n### Condition\n- Complication due to diabetes mellitus\n- Proliferative retinopathy due to type 2 diabetes mellitus\n- Primary diagnosis: Retinal neovascularization\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-04 13:40:14, ended at 2019-10-04 14:40:39\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n- Hypercalcemia\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2020-01-04, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-17 00:00:00, ended at 2019-10-17 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2019-10-19, presumably until 2020-03-09, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-18 00:00:00, ended at 2019-10-18 00:00:00\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- biotin, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbate manganese, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbyl tetraisopalmitate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- folic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- zinc ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- potassium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- 6-O-palmitoylascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- magnesium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- calcium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- sodium ascorbate, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n- ascorbic acid, through Oral route, started on 2019-10-20, presumably until 2020-02-25, with intended 3 refill(s). Instructions: take 1 mg by mouth daily AND 60 mg every day AND 300 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-20 12:25:42, ended at 2019-10-20 14:05:54\nThe patient in this visit was 46 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n- Primary diagnosis: Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-21 13:37:15, ended at 2019-10-21 15:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypersomnia\n- Gastroesophageal reflux disease without esophagitis\n- Nicotine dependence\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n- Cough\n\n### Drug\n- nicotine 2 MG Oral Lozenge, through Buccal route, started on 2019-10-21, presumably until 2021-05-16, with intended 6 refill(s). Instructions: place 2 mg inside cheek or to gum every 4 hours as needed\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2019-10-21, presumably until 2020-01-03, with intended 3 refill(s). Instructions: take 2 Tabs (40 mg total) by mouth daily\n- nicotine bitartrate, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n- nicotine, through Transdermal route, started on 2019-10-21, presumably until 2020-02-01, with intended 3 refill(s). Instructions: apply 14 mg to skin every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-28 12:36:49, ended at 2019-10-28 14:38:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-29 00:00:00, ended at 2019-10-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2019-10-29, presumably until 2022-07-30, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- furosemide 80 MG Oral Tablet, through Oral route, presumably until 2019-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q24H\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-08 00:00:00, ended at 2019-11-08 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-11-09 10:05:00, ended at 2019-11-09 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of hemodialysis access (including arterial inflow, body of access and venous outflow)\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-09 10:05:06, ended at 2019-11-09 16:40:03\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-22 11:58:27, ended at 2019-11-22 15:11:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Opioid abuse\n- Pulmonary hypertension\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- 0.5 UNT Doses 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2020-03-09, with intended 11 refill(s). Instructions: Inject 6 to 10 unit subcutaneously (under the skin) 3 times daily with meals according to sliding scale\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-23 00:00:00, ended at 2019-11-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Opioid abuse\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-26 13:07:20, ended at 2019-11-26 13:47:51\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Presbyopia\n- Primary diagnosis: Regular astigmatism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-06, presumably until 2019-12-15, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-09 12:11:19, ended at 2019-12-09 14:09:17\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Evaluation of auditory function for surgically implanted device(s) candidacy or postoperative status of a surgically implanted device(s); first hour\n- Diagnostic analysis of cochlear implant, age 7 years or older; subsequent reprogramming\n\n### Condition\n- Sensorineural hearing loss, bilateral\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-14 08:08:46, ended at 2019-12-14 09:14:42\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Interstitial lung disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-15 00:00:00, ended at 2019-12-15 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, started on 2019-12-16, presumably until 2020-03-06, with intended 0 refill(s). Instructions: take 1 Tab (12.5 mg total) by mouth 2 times a day as needed for Nausea\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-21 12:32:47, ended at 2019-12-21 15:44:55\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Opioid abuse\n- Retinal disorder\n- End-stage renal disease\n- Type 1 diabetes mellitus\n- Complication due to diabetes mellitus\n- Nicotine dependence\n- Polyneuropathy due to diabetes mellitus\n- Secondary diabetes mellitus\n- Primary diagnosis: Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 00:00:00, ended at 2019-12-29 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for closed chest procedures; (including bronchoscopy) not otherwise specified\n\n### Condition\n- Pulmonary hypertension\n- Lymph node sarcoidosis\n- Gastroesophageal reflux disease without esophagitis\n- Essential hypertension\n- Type 1 diabetes mellitus without complication\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- remifentanil 2 MG Injection, through Intravenous route, started on 2019-12-29, presumably until 2019-12-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-12-29, presumably until 2019-12-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-29 07:10:00, ended at 2019-12-29 10:09:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with transbronchial lung biopsy(s), single lobe\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial or endobronchial biopsy(s), single or multiple sites\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Radiologic examination, chest; single view\n\n### Condition\n- Chronic obstructive lung disease\n- Lymph node sarcoidosis\n- Old myocardial infarction\n- Primary diagnosis: Pulmonary hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Disorder of nervous system due to type 1 diabetes mellitus\n- Nicotine dependence\n- Essential hypertension\n- Heart failure\n- Post-inflammatory pulmonary fibrosis\n- Abnormal findings on diagnostic imaging of lung\n- Hyperlipidemia\n- Interstitial lung disease\n- Disorder of lung\n- Peripheral circulatory disorder due to type 1 diabetes mellitus\n- Sarcoidosis\n- Pulmonary sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-31 00:00:00, ended at 2019-12-31 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Interstitial lung disease\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-03 14:07:08, ended at 2020-01-03 15:25:08\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Primary diagnosis: Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-01-04 00:00:00, ended at 2020-01-04 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-04, presumably until 2020-01-05, with intended 1 refill(s). Instructions: take 2 Tabs (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-05 00:00:00, ended at 2020-01-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sarcoidosis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-01-05, presumably until 2020-06-08, with intended 2 refill(s). Instructions: take 3 Tabs (15 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:10:00, ended at 2020-01-06 12:24:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 29.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 55 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- MCV [Entitic volume] by Automated count: 102.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Erythrocyte sedimentation rate: 29 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 326 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperosmolarity\n- Hypercalcemia\n- Sarcoidosis\n- Secondary diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 12:25:00, ended at 2020-01-06 13:06:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Sarcoidosis\n- Closed fracture of second metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of first metatarsal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:07:00, ended at 2020-01-06 13:19:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; 2 views\n\n### Condition\n- Closed fracture of first metatarsal bone\n- Closed fracture of third metatarsal bone\n- Closed fracture of second metatarsal bone\n- Sarcoidosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Respiratory flow volume loop\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-06 13:20:00, ended at 2020-01-06 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing (eg, 6-minute walk test), including measurement of heart rate, oximetry, and oxygen titration, when performed\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n\n### Condition\n- Interstitial lung disease\n- Sarcoidosis\n- Dyspnea\n- Hyperosmolarity\n- Secondary diabetes mellitus\n- Hypercalcemia\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-06 14:09:28, ended at 2020-01-06 16:00:44\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-11 09:30:59, ended at 2020-01-11 10:16:22\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 8.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-12 10:30:00, ended at 2020-01-12 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus\n- Type 1 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-18 11:42:19, ended at 2020-01-18 12:43:33\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Closed fracture proximal phalanx, toe\n- Hyperglycemia due to type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-30 00:00:00, ended at 2020-01-30 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n\n### Drug\n- 24 HR nicotine 0.875 MG/HR Transdermal System, started on 2020-02-01, presumably until 2021-05-16, with intended 2 refill(s). Instructions: APPLY ONE PATCH EXTERNALLY ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-06 00:00:00, ended at 2020-02-06 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- calcium acetate 667 MG Oral Capsule, started on 2020-02-07, presumably until 2020-04-10, with intended 4 refill(s). Instructions: TAKE TWO CAPSULES BY MOUTH THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-02-10, with intended 0 refill(s). Instructions: Take 1 capsule now and then 1 after next 3 dialysis sessions.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-11 00:00:00, ended at 2020-02-11 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-11, presumably until 2020-02-24, with intended 0 refill(s). Instructions: APPLY TOPICALLY AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-15 10:15:00, ended at 2020-02-15 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n- Closed fracture proximal phalanx, toe\n- Closed fracture of first metatarsal bone\n- Hyperglycemia due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-15 10:38:28, ended at 2020-02-15 11:17:20\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 1 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-23 00:00:00, ended at 2020-02-23 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-02-24, presumably until 2020-05-08, with intended 3 refill(s). Instructions: apply to affected area topically as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-25 00:00:00, ended at 2020-02-25 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- ascorbate manganese, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbyl tetraisopalmitate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- folic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- zinc ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- potassium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- 6-O-palmitoylascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- magnesium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- calcium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- sodium ascorbate, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- ascorbic acid, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n- biotin, started on 2020-02-28, presumably until 2020-04-13, with intended 3 refill(s). Instructions: Take 1 tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2020-02-28, presumably until 2021-02-27, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed (SOB, Wheezing)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-05 00:00:00, ended at 2020-03-05 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- promethazine hydrochloride 12.5 MG Oral Tablet, started on 2020-03-06, presumably until 2021-03-14, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH TWICE A DAY AS NEEDED FOR NAUSEA \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet, started on 2020-03-09, presumably until 2020-08-04, with intended 5 refill(s). Instructions: DISSOLVE TWO TABLETS UNDER TONGUE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-09 12:18:40, ended at 2020-03-09 12:48:39\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Hyperglycemia due to type 1 diabetes mellitus\n- Nicotine dependence\n- Type 1 diabetes mellitus\n- Post-inflammatory pulmonary fibrosis\n- Primary diagnosis: Anemia\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- oseltamivir 30 MG Oral Capsule, started on 2020-02-10, presumably until 2020-04-06, with intended 0 refill(s)\n- 3 ML insulin lispro 200 UNT/ML Pen Injector, through Subcutaneous route, started on 2020-03-09, presumably until 2021-03-15, with intended 11 refill(s). Instructions: inject 6-10 Units subcutaneous (under the skin) before meals\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, started on 2020-03-09, presumably until 2021-03-19, with intended 11 refill(s). Instructions: Inject 30 units under the skin at bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-03-22 00:00:00, ended at 2020-03-22 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus\n- Primary diagnosis: Renal disorder due to type 1 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 1 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-24 13:41:40, ended at 2020-03-24 13:51:46\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-28 09:16:21, ended at 2020-03-28 09:27:19\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Opioid dependence\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-06 14:27:38, ended at 2020-04-06 15:01:14\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Primary diagnosis: Sarcoidosis\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Type 2 diabetes mellitus\n\n### Drug\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2020-04-06, presumably until 2020-09-28, with intended 2 refill(s). Instructions: take 4 Tabs (4 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-13 14:48:23, ended at 2020-04-13 15:32:30\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Dyspnea\n- Interstitial lung disease\n- Primary diagnosis: Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-20 10:33:00, ended at 2020-04-20 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, lower extremity; without contrast material\n\n### Condition\n- Hyperglycemia due to type 1 diabetes mellitus\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Renal disorder due to type 1 diabetes mellitus\n- Type 1 diabetes mellitus\n- Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dyspnea\n- Sarcoidosis\n- Primary diagnosis: Interstitial lung disease\n- Post-inflammatory pulmonary fibrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-04-26 00:00:00, ended at 2020-04-26 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, started on 2020-04-26, presumably until 2021-06-14, with intended 12 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-02 00:00:00, ended at 2020-05-02 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain in left foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-04 08:28:00, ended at 2020-05-04 23:59:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Autonomic neuropathy due to type 2 diabetes mellitus\n- Pain in left foot\n- Neuropathic arthropathy due to type 2 diabetes mellitus\n- Arthropathy of the ankle AND/OR foot associated with a neurological disorder\n- Type 2 diabetes mellitus\n- Onychomycosis due to dermatophyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-07 00:00:00, ended at 2020-05-07 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, started on 2020-05-08, presumably until 2020-10-10, with intended 11 refill(s). Instructions: APPLY TOPICALLY TO THE AFFECTED AREA AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-17 00:00:00, ended at 2020-05-17 00:00:00\nThe patient in this visit was 47 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, started on 2020-05-17, presumably until 2021-04-09, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "158c09c66bbc2808a3e20c763d96a3c5eed1be8e0ff71a701fa5d42ab1404da8", "prompt_hash": "ad542508c3ccaf91ccc581fbfa22f5d8029ad6814b04850fa0c07e2b980dbd57", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 2, "doc": {"person_id": 115967868, "visit_occurrence_id": 45095824, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2011-08-30 00:00:00", "visit_end_datetime": "2011-08-30 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2009-07-11 13:00:00", "patient_last_visit_date": "2021-07-02 00:00:00", "end_obs_date": "2012-08-29", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "recurrent", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 5721, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-11 13:00:00, ended at 2009-07-11 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2012-03-24. Instructions: take by mouth 2 times a day. \n- valsartan 160 MG Oral Tablet, through Oral route, presumably until 2013-05-04. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth daily. \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2009-07-19. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-18 11:30:00, ended at 2009-07-18 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. Call if lightheaded\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-20 10:54:00, ended at 2009-07-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-07-25 09:45:00, ended at 2009-07-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.69 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 12.3 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- atenolol 50 MG Oral Tablet, through Oral route, presumably until 2010-02-20. Instructions: take by mouth. \n- allopurinol 300 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth. \n- terazosin 5 MG Oral Tablet, through Oral route. Instructions: take by mouth. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-07-26 08:45:00, ended at 2009-07-31 12:18:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 42.1 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.28 (thousand per microliter)\n- Prothrombin time (PT): 16.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 60.5 (millimeter mercury column)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 28.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 640 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 203 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Essential hypertension\n- Alcohol abuse\n- Complication of surgical procedure\n- Gout\n- Disorder of lung\n- Drug abuse, continuous\n- Primary malignant neoplasm of lower lobe, bronchus or lung\n- Hyperlipidemia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2009-07-27, presumably until 2009-07-31\n- terazosin 5 MG Oral Capsule, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- lisinopril 40 MG Oral Tablet, through Oral route, started on 2009-07-30, presumably until 2009-07-31\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-31\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2009-07-27, presumably until 2009-07-27\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-07-28, presumably until 2009-07-30\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-30\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-07-30, presumably until 2010-02-20, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2009-07-27, presumably until 2009-07-31\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-29\n- valsartan 160 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-07-26, presumably until 2009-07-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-07-27, presumably until 2009-07-31\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2009-07-30, presumably until 2009-07-31\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2009-07-26, presumably until 2009-07-30\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-27\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2009-07-29, presumably until 2009-07-31\n- morphine sulfate 1 MG/ML Injection, through Intravenous route, started on 2009-07-27, presumably until 2009-07-27\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2009-07-26, presumably until 2009-07-26\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2009-07-28, presumably until 2009-07-31\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-07-31, presumably until 2010-01-27, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-08-12 13:49:00, ended at 2009-08-12 19:26:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.08 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Generalized aches and pains\n- Chest pain\n\n### Drug\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-12, presumably until 2009-08-12\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2009-08-12, presumably until 2009-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-22 10:30:00, ended at 2009-08-22 10:42:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-25 16:07:00, ended at 2009-08-25 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-19 08:55:00, ended at 2010-02-19 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Pleural effusion\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:14:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 75 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8.898\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route. Instructions: take by mouth daily. \n- carvedilol 12.5 MG Oral Tablet, through Oral route, presumably until 2014-04-05. Instructions: take by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-01 00:00:00, ended at 2010-08-01 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-21 08:25:00, ended at 2010-08-21 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Disorder of lung\n- Lung field abnormal\n- Pleural effusion\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-28 10:12:00, ended at 2010-08-28 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-01-29 00:00:00, ended at 2011-01-29 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-07 16:59:00, ended at 2011-02-07 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-08 13:36:00, ended at 2011-02-08 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; cervical\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; lumbar\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, without contrast material, followed by contrast material(s) and further sequences; thoracic\n\n### Condition\n- Lumbosacral spondylosis without myelopathy\n- Cervical spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-11 08:11:00, ended at 2011-02-11 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Pleural effusion\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-18 09:50:46, ended at 2011-02-18 15:26:56\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-26 09:25:00, ended at 2011-02-26 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-03-01 09:40:00, ended at 2011-03-01 23:59:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Pleural effusion\n- Degeneration of intervertebral disc\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-03-06 00:00:00, ended at 2011-03-06 00:00:00\nThe patient in this visit was 76 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-12 14:44:00, ended at 2011-08-12 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-13 09:23:00, ended at 2011-08-13 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of lung\n- Lung field abnormal\n- Primary malignant neoplasm of respiratory tract\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 09:45:00, ended at 2011-08-27 10:37:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-08-27 10:38:00, ended at 2011-08-27 23:59:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-30 00:00:00, ended at 2011-08-30 00:00:00\nThe patient in this visit was 77 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3e234eef2f4784129299218fc963ede935b7b9ed6a95e0bf1129d432342fe88c", "prompt_hash": "38cb4193e2a1dfb960fbf3b6e999382719c793df3e6376b4fd28d9f35aae8451", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115968081, "visit_occurrence_id": 180687774, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2021-05-08 06:57:00", "visit_end_datetime": "2021-05-08 23:59:00", "visit_length_in_hours": 17.033333333333335, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 118, "patient_first_visit_date": "2011-01-09 10:37:00", "patient_last_visit_date": "2023-02-04 11:16:39", "end_obs_date": "2022-05-08", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 1, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 1, "visit_sequence_number": 37, "cumulated_visit_num": 37, "cumulated_approximate_token_count": 9832, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2011-01-09 10:37:00, ended at 2011-01-29 15:45:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.7 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 415 (unit per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 1.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 49.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 32.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 96 (millimeter mercury column)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.73 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 61.8 (second)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 13.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Base deficit in Blood: 9.0 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 15 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Aortocoronary bypass of two coronary arteries\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Catheterization of both left and right heart\n- Operative external blood circulation\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Coronary angiography\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Insertion of intra-aortic balloon counterpulsation\n- Single internal mammary-coronary artery bypass\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Controlled ventilation procedure and therapy, initiation and management\n- Occupational therapy evaluation\n\n### Condition\n- Congestive heart failure\n- Obesity\n- Obstructive sleep apnea syndrome\n- Postprocedural state finding\n- Acute respiratory failure\n- Peripheral vascular disease\n- Pulmonary congestion and hypostasis\n- Brachial radiculitis\n- Coronary arteriosclerosis\n- Essential hypertension\n- Glaucoma\n- Leukocytosis\n- Primary diagnosis: Acute myocardial infarction\n- Aortocoronary bypass graft present\n- Cardiomegaly\n- Hyperlipidemia\n- Acute combined systolic and diastolic heart failure\n- Cardiac arrhythmia\n- Chronic systolic heart failure\n- Hemorrhoids\n- Nuclear senile cataract\n- Sequelae of cardiovascular disorders\n- Type 2 diabetes mellitus without complication\n- Acute myocardial infarction of anterolateral wall\n- Chronic ischemic heart disease\n- Pleural effusion\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-02-15, with quantity of 15.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-01-20, presumably until 2011-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2011-01-18, presumably until 2011-01-21\n- warfarin sodium 6 MG Oral Tablet, through Oral route, started on 2011-01-28, presumably until 2011-01-28\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-01-11, presumably until 2011-01-11\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-26\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-04-19. Instructions: take 25 mg by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-01-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-20\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2011-01-19, presumably until 2011-01-23\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2011-01-12, presumably until 2011-01-28\n- hydrocortisone 25 MG/ML Topical Cream, through Topical route, started on 2011-01-27, presumably until 2011-04-19, with quantity of 1.0, with intended 0 refill(s). Instructions: insert into the rectum as needed for Anorectal itching/discomfort. \n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2012-01-29, with quantity of 120.0, with intended 0 refill(s). Instructions: take 4 Tabs by mouth 2 times a day. \n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2011-01-09, presumably until 2011-01-09\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-01-12, presumably until 2011-01-28\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-01-14, presumably until 2012-01-29, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed \n- furosemide 40 MG Oral Tablet, through Oral route, started on 2011-01-27, presumably until 2012-01-29, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-13, presumably until 2020-04-28. Instructions: inject subcutaneous (under the skin). \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2011-01-16, presumably until 2011-01-29. Instructions: take by mouth.\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2011-01-17, presumably until 2011-01-29\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-01-13, presumably until 2011-01-26\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-14\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2011-01-22, presumably until 2011-01-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-01-09, presumably until 2011-01-13\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-01-28. Instructions: take 20 mg by mouth daily.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-01-11, presumably until 2011-01-14\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2011-01-09, presumably until 2022-08-20. Instructions: inject subcutaneous (under the skin) 4 times a day before meals and bedtime. \n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2011-01-20, presumably until 2011-01-26\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2011-01-15, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-13\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-11\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2011-01-14, presumably until 2011-01-14\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2011-01-13, presumably until 2011-01-13\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2011-01-26, presumably until 2011-02-15, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2011-01-29, presumably until 2011-01-29, with quantity of 90.0, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily. Please have INR levels checked on Monday 02/01/2011 \n- pravastatin sodium 10 MG Oral Tablet, through Oral route, presumably until 2011-02-15. Instructions: take 20 mg by mouth daily. \n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-01-17, presumably until 2011-01-28\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2011-01-25, presumably until 2011-01-25\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-01-13, presumably until 2011-04-19, with quantity of 60.0, with intended 2 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed \n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2011-01-11, presumably until 2011-01-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-01-10, presumably until 2011-02-15, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast. \n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2011-01-12, presumably until 2011-01-12\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-01-23, presumably until 2011-04-19, with quantity of 60.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2011-01-11, presumably until 2011-01-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-10 14:38:57, ended at 2011-01-10 15:15:45\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Precordial pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-18 09:29:44, ended at 2011-01-18 10:42:10\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-01-29 10:00:00, ended at 2011-01-29 23:59:00\nThe patient in this visit was 61 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-29 00:00:00, ended at 2020-01-29 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cancer Ag 19-9 [Units/volume] in Serum or Plasma: 2 (unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-01 08:29:50, ended at 2020-02-01 10:34:41\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2020-01-28, presumably until 2020-01-28, with intended 0 refill(s). Instructions: take 1 Tablet (300 mg total) by mouth daily\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2019-10-23, presumably until 2019-10-23, with intended 0 refill(s). Instructions: take 1 Tablet (20 mg total) by mouth AM\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-04-12, presumably until 2022-11-09, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2019-10-25, presumably until 2022-03-01, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- vitamin B complex, through Oral route, started on 2012-07-25, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Capsule by mouth daily\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2019-07-23, presumably until 2019-07-23, with intended 0 refill(s). Instructions: take 1 Tablet (150 mg total) by mouth AM\n- dorzolamide 20 MG/ML Ophthalmic Solution, through Intraocular route, started on 2019-08-17, presumably until 2019-08-17, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day\n- spironolactone 25 MG Oral Tablet, started on 2017-08-15, presumably until 2017-08-15, with intended 0 refill(s). Instructions: Take one tablet by mouth one time daily\n- 3 ML insulin glargine 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2017-08-19, presumably until 2017-08-19, with intended 0 refill(s). Instructions: inject 60 Units subcutaneous (under the skin) 2 times a day\n- 24 HR metformin hydrochloride 500 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-30, presumably until 2019-12-30, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-01-07, presumably until 2020-01-07, with intended 0 refill(s). Instructions: inject subcutaneous (under the skin) every 7 days Every Mondays\n- rosuvastatin calcium 20 MG Oral Tablet, started on 2019-08-24, presumably until 2019-08-24, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2019-11-15, presumably until 2019-11-15, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-01 10:33:00, ended at 2020-02-01 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 47.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 13 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.38 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.43 (million per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 46 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.67 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.21 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 69.0 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 72 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-18 00:00:00, ended at 2020-02-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 07:12:00, ended at 2020-03-31 08:24:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Liver cell carcinoma\n- Lumbar spondylosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 08:25:00, ended at 2020-03-31 10:25:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-03-31 13:22:00, ended at 2020-03-31 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Portal vein thrombosis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-04 00:00:00, ended at 2020-04-04 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 00:00:00, ended at 2020-04-15 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-18 00:00:00, ended at 2020-04-18 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-18 10:04:44, ended at 2020-04-18 10:16:59\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-22 07:47:00, ended at 2020-04-22 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n\n### Condition\n- Postoperative state\n- Steatosis of liver\n- Disorder of digestive system\n- Hepatosplenomegaly\n- Liver cell carcinoma\n- Acquired absence of organ\n- Disease of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-28 09:33:22, ended at 2020-04-28 10:35:04\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Malignant neoplasm of liver\n- Traumatic or non-traumatic injury\n- Obstructive sleep apnea syndrome\n- Generalized ischemic myocardial dysfunction\n- Hyperlipidemia\n- Primary diagnosis: COVID-19\n- Liver cell carcinoma\n\n### Drug\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, presumably until 2020-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 Tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for non-invasive imaging or radiation therapy\n\n### Condition\n- Liver cell carcinoma\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- cefazolin 1000 MG Injection, started on 2020-05-01, presumably until 2020-05-01\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-05-01 08:40:00, ended at 2020-05-01 19:30:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.32 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- MCV [Entitic volume] by Automated count: 88.6 (femtoliter)\n- Body height: 5' 6\" (inch (US))\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 223 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n\n### Procedure\n- Ablation, 1 or more liver tumor(s), percutaneous, radiofrequency\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Computed tomography guidance for, and monitoring of, parenchymal tissue ablation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Aortocoronary bypass graft present\n- Steatosis of liver\n- Hyperlipidemia\n- Old myocardial infarction\n- Supraventricular tachycardia\n- Chronic systolic heart failure\n- Primary diagnosis: Liver cell carcinoma\n- Generalized ischemic myocardial dysfunction\n- Chronic congestive heart failure\n- Hypertensive heart failure\n- Obesity\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-05-01, presumably until 2020-05-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-24 00:00:00, ended at 2020-06-24 00:00:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-04 10:32:19, ended at 2020-07-04 10:56:47\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n- Portal vein thrombosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-05 07:00:00, ended at 2020-08-05 23:59:00\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:46:06, ended at 2020-08-06 09:13:34\nThe patient in this visit was 70 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-07 00:00:00, ended at 2020-08-07 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-15 10:36:58, ended at 2020-08-15 11:02:37\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Liver\n- Portal vein thrombosis\n- Cirrhosis of liver\n- Nonalcoholic steatohepatitis\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-11-05 07:10:00, ended at 2020-11-05 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 09:54:20, ended at 2020-11-14 10:11:20\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-01-12 00:00:00, ended at 2021-01-12 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.56 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-06 00:00:00, ended at 2021-02-06 00:00:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-12 12:59:00, ended at 2021-02-12 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Portal hypertension\n- Splenomegaly\n- Liver cell carcinoma\n- Cirrhosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-13 10:28:20, ended at 2021-02-13 10:49:11\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nonalcoholic steatohepatitis\n- Cirrhosis of liver\n- Primary diagnosis: Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-05-08 06:57:00, ended at 2021-05-08 23:59:00\nThe patient in this visit was 71 years old, Asian, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Cirrhosis of liver\n- Liver cell carcinoma\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "abfba416c551706ccd9b2ad7a2e8092272b4a5a72b4641e93b07d59ef6160e50", "prompt_hash": "b86c7589f17258e8b1a1ff4cbe9d3893a584a2fa8329ca9937b18bd40c430007", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 4, "doc": {"person_id": 115968294, "visit_occurrence_id": 61839720, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2014-04-10 14:30:00", "visit_end_datetime": "2014-04-10 23:59:00", "visit_length_in_hours": 9.483333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 14:30:00, ended at 2014-04-10 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 91, "patient_first_visit_date": "2012-09-21 00:00:00", "patient_last_visit_date": "2022-06-22 00:00:00", "end_obs_date": "2015-04-10", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "recurrent", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 101, "cumulated_visit_num": 101, "cumulated_approximate_token_count": 32208, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-21 15:02:00, ended at 2012-09-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route. Instructions: take 5 mg by mouth daily.  \n- pioglitazone 15 MG Oral Tablet, through Oral route, presumably until 2013-04-04. Instructions: take 15 mg by mouth daily.  \n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2012-10-19. Instructions: take  by mouth.  \n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2014-10-23. Instructions: take 40 mg by mouth daily.  \n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 0.4 mg by mouth Every Day.\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, presumably until 2012-10-19. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-25 00:00:00, ended at 2012-09-25 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-15 12:00:00, ended at 2012-10-15 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-16 12:29:00, ended at 2012-10-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Postprocedural state finding\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-19 08:55:00, ended at 2012-10-19 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.079\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-10-25 00:00:00, ended at 2012-10-25 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; partial hepatectomy or management of liver hemorrhage (excluding liver biopsy)\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- cefazolin 1000 MG Injection, started on 2012-10-25, presumably until 2012-10-25\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-10-25 11:40:00, ended at 2012-10-31 11:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.72 (thousand per microliter)\n- Prothrombin time (PT): 14.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 277 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Partial hepatectomy\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of other bile duct\n- Anastomosis of hepatic duct to gastrointestinal tract\n- Excision of regional lymph nodes\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Foreign body granuloma of subcutaneous tissue\n- Benign prostatic hyperplasia without outflow obstruction\n- Inflammatory dermatosis\n- Primary malignant neoplasm of gallbladder\n- Type 2 diabetes mellitus without complication\n- Carcinoma in situ of liver and/or biliary system\n- Essential hypertension\n- Primary malignant neoplasm of biliary tract\n- Acquired absence of organ\n- Hyperlipidemia\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-28, presumably until 2012-10-28\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2012-10-30, presumably until 2012-10-30\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-28\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-11-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- hydrocortisone 5 MG/ML Topical Cream, through Topical route, started on 2012-10-29, presumably until 2012-11-09, with intended 0 refill(s). Instructions: Please apply thin film to rash once to twice daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-31\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-26, presumably until 2012-10-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-31\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-10-26, presumably until 2012-10-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-30, presumably until 2012-12-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-26, presumably until 2012-10-31\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2012-10-26, presumably until 2012-10-29\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-11-09, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-09 07:23:00, ended at 2012-11-09 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.079\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of intrahepatic bile duct\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-11-09, presumably until 2012-12-07, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-22 12:59:00, ended at 2012-11-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 08:59:00, ended at 2012-12-07 09:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.53 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 09:50:00, ended at 2012-12-07 12:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Imaging of abdomen abnormal\n- Primary diagnosis: Disorder of gallbladder\n- Incisional hernia\n- Secondary malignant neoplasm of intra-abdominal organs\n- Disease of liver\n- Primary malignant neoplasm of gallbladder\n- Acquired absence of organ\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 12:57:00, ended at 2012-12-07 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Lung field abnormal\n- Disorder of gallbladder\n- Lymphadenopathy\n- Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 07:57:00, ended at 2012-12-13 08:48:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.47 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n- Primary malignant neoplasm of gallbladder\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 08:49:00, ended at 2012-12-13 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- sodium chloride 9 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 07:40:00, ended at 2012-12-20 07:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 07:57:00, ended at 2012-12-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.0 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 120 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-28 13:45:00, ended at 2012-12-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-02 10:12:00, ended at 2013-01-02 10:54:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 309 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-02 10:55:00, ended at 2013-01-02 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.75\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-03 09:30:00, ended at 2013-01-03 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-03, presumably until 2013-01-03\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-03, presumably until 2013-01-03\n- sodium chloride 9 MG/ML Injection, started on 2013-01-03, presumably until 2013-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-03, presumably until 2013-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-10 08:40:00, ended at 2013-01-10 09:05:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-10, presumably until 2013-01-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-10, presumably until 2013-01-10\n- sodium chloride 9 MG/ML Injection, started on 2013-01-10, presumably until 2013-01-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-10, presumably until 2013-01-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-10 09:06:00, ended at 2013-01-10 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-24 08:18:00, ended at 2013-01-24 08:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 231 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-24 09:00:00, ended at 2013-01-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n- Constipation\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-24, presumably until 2013-01-24\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-24, presumably until 2013-01-24\n- sodium chloride 9 MG/ML Injection, started on 2013-01-24, presumably until 2013-01-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, presumably until 2014-04-10. Instructions: take  by mouth daily.  \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-24, presumably until 2013-01-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-31 09:29:00, ended at 2013-01-31 09:31:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 35 (percent)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 50 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-31 09:32:00, ended at 2013-01-31 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-14 09:22:00, ended at 2013-02-14 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Blood chemistry abnormal\n- Abnormal glucose level\n- Disorder of gallbladder\n- Hematopoietic system finding\n- Primary malignant neoplasm of gallbladder\n- Constipation\n- Drug-induced neutropenia\n- Acquired absence of organ\n- Secondary malignant neoplasm of intra-abdominal organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-14 10:00:00, ended at 2013-02-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n- Constipation\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-02-14, presumably until 2013-02-14\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-02-14, presumably until 2013-02-14\n- sodium chloride 9 MG/ML Injection, started on 2013-02-14, presumably until 2013-02-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-14, presumably until 2013-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 10:20:00, ended at 2013-02-28 10:26:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-02-28, presumably until 2013-02-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-02-28, presumably until 2013-02-28\n- sodium chloride 9 MG/ML Injection, started on 2013-02-28, presumably until 2013-02-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-28, presumably until 2013-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 10:27:00, ended at 2013-02-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.05 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Constipation\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-14 09:23:00, ended at 2013-03-14 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.33 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n- Constipation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-14 10:00:00, ended at 2013-03-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Constipation\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-03-14, presumably until 2013-03-14\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-03-14, presumably until 2013-03-14\n- sodium chloride 9 MG/ML Injection, started on 2013-03-14, presumably until 2013-03-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-14, presumably until 2013-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-26 13:56:00, ended at 2013-03-26 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Hernia of anterior abdominal wall\n- Disorder of gallbladder\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 09:20:00, ended at 2013-03-28 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Constipation\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 10:00:00, ended at 2013-03-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-04 12:48:00, ended at 2013-04-04 14:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-04 14:30:00, ended at 2013-04-04 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- capecitabine 500 MG Oral Tablet, started on 2013-04-04, presumably until 2013-07-04, with intended 0 refill(s). Instructions: xeloda 2000 mg po bid only with radiation therapy Monday through Friday x 5.5 wks, #224\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-05 13:31:00, ended at 2013-04-05 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-16 14:03:00, ended at 2013-04-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Acquired absence of organ\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Carcinoma in situ of liver and/or biliary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-22 13:45:00, ended at 2013-04-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology treatment planning; complex\n- Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-23 09:15:00, ended at 2013-04-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-24 14:19:00, ended at 2013-04-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-25 15:03:00, ended at 2013-04-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-26 14:11:00, ended at 2013-04-26 14:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-26 14:57:00, ended at 2013-04-26 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 129 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-29 13:06:00, ended at 2013-04-29 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-30 13:18:00, ended at 2013-04-30 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-01 13:24:00, ended at 2013-05-01 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-02 13:17:00, ended at 2013-05-02 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-03 13:13:00, ended at 2013-05-03 13:50:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-03 13:51:00, ended at 2013-05-03 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-07 13:40:00, ended at 2013-05-07 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-08 14:14:00, ended at 2013-05-08 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-09 13:22:00, ended at 2013-05-09 14:10:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-09 14:11:00, ended at 2013-05-09 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-10 13:31:00, ended at 2013-05-10 14:23:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-10 14:24:00, ended at 2013-05-10 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of gallbladder\n- Carcinoma in situ of liver and/or biliary system\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-13 13:14:00, ended at 2013-05-13 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Diarrhea\n- Hernia of anterior abdominal wall\n- Carcinoma in situ of liver and/or biliary system\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-14 13:16:00, ended at 2013-05-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-15 13:21:00, ended at 2013-05-15 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-16 13:26:00, ended at 2013-05-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-17 13:18:00, ended at 2013-05-17 14:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-17 14:30:00, ended at 2013-05-17 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 127 (thousand per microliter)\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Collection of venous blood by venipuncture\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-20 11:40:00, ended at 2013-05-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-21 13:10:00, ended at 2013-05-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-22 13:19:00, ended at 2013-05-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-23 13:18:00, ended at 2013-05-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-24 00:00:00, ended at 2013-05-24 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Convalescence after radiotherapy\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 13:30:00, ended at 2013-05-24 14:09:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 14:10:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 115 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Collection of venous blood by venipuncture\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Acquired absence of organ\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-27 13:17:00, ended at 2013-05-27 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-28 13:23:00, ended at 2013-05-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-29 13:20:00, ended at 2013-05-29 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-06 14:48:00, ended at 2013-06-06 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 16:08:00, ended at 2013-06-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-28 12:46:00, ended at 2013-06-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Convalescence after radiotherapy\n- Lung field abnormal\n- Hernia of anterior abdominal wall\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-04 00:00:00, ended at 2013-07-04 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 13:39:00, ended at 2013-07-04 14:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Convalescence after radiotherapy\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 14:45:00, ended at 2013-07-04 15:43:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 15:44:00, ended at 2013-07-04 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 256 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-05 13:32:00, ended at 2013-07-05 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-23 15:51:00, ended at 2013-07-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 327 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-31 00:00:00, ended at 2013-07-31 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-30 16:54:00, ended at 2013-08-30 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-27 13:55:00, ended at 2013-09-27 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 229 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-30 16:00:00, ended at 2013-09-30 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-03 00:00:00, ended at 2013-10-03 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Convalescence after radiotherapy\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-03 14:00:00, ended at 2013-10-03 14:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- mupirocin 20 MG/ML Topical Cream, through Topical route, presumably until 2014-04-10. Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-03 15:00:00, ended at 2013-10-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-24 11:22:00, ended at 2013-12-24 13:07:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 249 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-24 13:08:00, ended at 2013-12-24 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of gallbladder\n- Postprocedural state finding\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-02 00:00:00, ended at 2014-01-02 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-02 14:00:00, ended at 2014-01-02 14:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-02 15:00:00, ended at 2014-01-02 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 12:58:00, ended at 2014-01-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-01 12:19:00, ended at 2014-04-01 14:37:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.70 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 259 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-01 14:38:00, ended at 2014-04-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Swelling / lump finding\n- Disorder of gallbladder\n- Lung field abnormal\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 13:30:00, ended at 2014-04-10 14:29:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 14:30:00, ended at 2014-04-10 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-21 00:00:00, ended at 2012-09-21 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-09-21 15:02:00, ended at 2012-09-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- finasteride 5 MG Oral Tablet, through Oral route. Instructions: take 5 mg by mouth daily.  \n- pioglitazone 15 MG Oral Tablet, through Oral route, presumably until 2013-04-04. Instructions: take 15 mg by mouth daily.  \n- cetirizine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2012-10-19. Instructions: take  by mouth.  \n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2014-10-23. Instructions: take 40 mg by mouth daily.  \n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 0.4 mg by mouth Every Day.\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, presumably until 2012-10-19. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-09-25 00:00:00, ended at 2012-09-25 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-15 12:00:00, ended at 2012-10-15 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-16 12:29:00, ended at 2012-10-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n\n### Condition\n- Postprocedural state finding\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-19 08:55:00, ended at 2012-10-19 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.079\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-10-25 00:00:00, ended at 2012-10-25 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; partial hepatectomy or management of liver hemorrhage (excluding liver biopsy)\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- cefazolin 1000 MG Injection, started on 2012-10-25, presumably until 2012-10-25\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-10-25, presumably until 2012-10-25\n- midazolam 1 MG/ML Injectable Solution, started on 2012-10-25, presumably until 2012-10-25\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2012-10-25, presumably until 2012-10-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-10-25 11:40:00, ended at 2012-10-31 11:15:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.72 (thousand per microliter)\n- Prothrombin time (PT): 14.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 277 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Partial hepatectomy\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Excision of other bile duct\n- Anastomosis of hepatic duct to gastrointestinal tract\n- Excision of regional lymph nodes\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Foreign body granuloma of subcutaneous tissue\n- Benign prostatic hyperplasia without outflow obstruction\n- Inflammatory dermatosis\n- Primary malignant neoplasm of gallbladder\n- Type 2 diabetes mellitus without complication\n- Carcinoma in situ of liver and/or biliary system\n- Essential hypertension\n- Primary malignant neoplasm of biliary tract\n- Acquired absence of organ\n- Hyperlipidemia\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-10-28, presumably until 2012-10-28\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2012-10-30, presumably until 2012-10-30\n- finasteride 5 MG Oral Tablet, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2012-10-25, presumably until 2012-10-28\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-11-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- hydrocortisone 5 MG/ML Topical Cream, through Topical route, started on 2012-10-29, presumably until 2012-11-09, with intended 0 refill(s). Instructions: Please apply thin film to rash once to twice daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-31\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-30\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2012-10-26, presumably until 2012-10-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-10-31\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-10-26, presumably until 2012-10-29\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-10-30, presumably until 2012-12-07, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-10-26, presumably until 2012-10-31\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2012-10-26, presumably until 2012-10-29\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-10-26, presumably until 2012-10-31\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-10-30, presumably until 2012-11-09, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-09 07:23:00, ended at 2012-11-09 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.079\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of intrahepatic bile duct\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-11-09, presumably until 2012-12-07, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-22 12:59:00, ended at 2012-11-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2012-11-22, presumably until 2014-04-10, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 08:59:00, ended at 2012-12-07 09:49:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.53 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.7 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 09:50:00, ended at 2012-12-07 12:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lung\n- Imaging of abdomen abnormal\n- Primary diagnosis: Disorder of gallbladder\n- Incisional hernia\n- Secondary malignant neoplasm of intra-abdominal organs\n- Disease of liver\n- Primary malignant neoplasm of gallbladder\n- Acquired absence of organ\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-07 12:57:00, ended at 2012-12-07 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Lung field abnormal\n- Disorder of gallbladder\n- Lymphadenopathy\n- Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 07:57:00, ended at 2012-12-13 08:48:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.47 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 189 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n- Primary malignant neoplasm of gallbladder\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 08:49:00, ended at 2012-12-13 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- sodium chloride 9 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 07:40:00, ended at 2012-12-20 07:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-20 07:57:00, ended at 2012-12-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 47.0 (percent)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 38.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 120 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-28 13:45:00, ended at 2012-12-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-02 10:12:00, ended at 2013-01-02 10:54:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 309 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-02 10:55:00, ended at 2013-01-02 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.75\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-03 09:30:00, ended at 2013-01-03 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-03, presumably until 2013-01-03\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-03, presumably until 2013-01-03\n- sodium chloride 9 MG/ML Injection, started on 2013-01-03, presumably until 2013-01-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-03, presumably until 2013-01-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-10 08:40:00, ended at 2013-01-10 09:05:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-10, presumably until 2013-01-10\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-10, presumably until 2013-01-10\n- sodium chloride 9 MG/ML Injection, started on 2013-01-10, presumably until 2013-01-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-10, presumably until 2013-01-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-10 09:06:00, ended at 2013-01-10 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.15 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.4 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.5 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-24 08:18:00, ended at 2013-01-24 08:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 1.95 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 231 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 308 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 47.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-24 09:00:00, ended at 2013-01-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n- Constipation\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-01-24, presumably until 2013-01-24\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-01-24, presumably until 2013-01-24\n- sodium chloride 9 MG/ML Injection, started on 2013-01-24, presumably until 2013-01-24\n- docusate sodium 250 MG Oral Capsule, through Oral route, presumably until 2014-04-10. Instructions: take  by mouth daily.  \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-01-24, presumably until 2013-01-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-31 09:29:00, ended at 2013-01-31 09:31:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 35 (percent)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Manual count: 1.3 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.3 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 50 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-31 09:32:00, ended at 2013-01-31 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-14 09:22:00, ended at 2013-02-14 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.30 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Blood chemistry abnormal\n- Abnormal glucose level\n- Disorder of gallbladder\n- Hematopoietic system finding\n- Primary malignant neoplasm of gallbladder\n- Constipation\n- Drug-induced neutropenia\n- Acquired absence of organ\n- Secondary malignant neoplasm of intra-abdominal organs\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-14 10:00:00, ended at 2013-02-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n- Constipation\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-02-14, presumably until 2013-02-14\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-02-14, presumably until 2013-02-14\n- sodium chloride 9 MG/ML Injection, started on 2013-02-14, presumably until 2013-02-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-14, presumably until 2013-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 10:20:00, ended at 2013-02-28 10:26:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.748\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-02-28, presumably until 2013-02-28\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-02-28, presumably until 2013-02-28\n- sodium chloride 9 MG/ML Injection, started on 2013-02-28, presumably until 2013-02-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-28, presumably until 2013-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 10:27:00, ended at 2013-02-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.2 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.05 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 160 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Constipation\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-14 09:23:00, ended at 2013-03-14 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.33 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n- Constipation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-14 10:00:00, ended at 2013-03-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n\n### Condition\n- Constipation\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2013-03-14, presumably until 2013-03-14\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2013-03-14, presumably until 2013-03-14\n- sodium chloride 9 MG/ML Injection, started on 2013-03-14, presumably until 2013-03-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-14, presumably until 2013-03-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-26 13:56:00, ended at 2013-03-26 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Hernia of anterior abdominal wall\n- Disorder of gallbladder\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 09:20:00, ended at 2013-03-28 09:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 51.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.24 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Constipation\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-28 10:00:00, ended at 2013-03-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-04 12:48:00, ended at 2013-04-04 14:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-04 14:30:00, ended at 2013-04-04 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- capecitabine 500 MG Oral Tablet, started on 2013-04-04, presumably until 2013-07-04, with intended 0 refill(s). Instructions: xeloda 2000 mg po bid only with radiation therapy Monday through Friday x 5.5 wks, #224\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-05 13:31:00, ended at 2013-04-05 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.669\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-16 14:03:00, ended at 2013-04-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography guidance for placement of radiation therapy fields\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Acquired absence of organ\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Carcinoma in situ of liver and/or biliary system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-22 13:45:00, ended at 2013-04-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology treatment planning; complex\n- Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-23 09:15:00, ended at 2013-04-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-24 14:19:00, ended at 2013-04-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-25 15:03:00, ended at 2013-04-25 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-26 14:11:00, ended at 2013-04-26 14:56:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-26 14:57:00, ended at 2013-04-26 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.5 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 129 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-29 13:06:00, ended at 2013-04-29 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-30 13:18:00, ended at 2013-04-30 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-01 13:24:00, ended at 2013-05-01 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-02 13:17:00, ended at 2013-05-02 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-03 13:13:00, ended at 2013-05-03 13:50:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-03 13:51:00, ended at 2013-05-03 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-07 13:40:00, ended at 2013-05-07 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-08 14:14:00, ended at 2013-05-08 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-09 13:22:00, ended at 2013-05-09 14:10:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-09 14:11:00, ended at 2013-05-09 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-10 13:31:00, ended at 2013-05-10 14:23:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-10 14:24:00, ended at 2013-05-10 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 2.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired absence of organ\n- Primary malignant neoplasm of gallbladder\n- Carcinoma in situ of liver and/or biliary system\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-13 13:14:00, ended at 2013-05-13 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Diarrhea\n- Hernia of anterior abdominal wall\n- Carcinoma in situ of liver and/or biliary system\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-14 13:16:00, ended at 2013-05-14 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-15 13:21:00, ended at 2013-05-15 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-16 13:26:00, ended at 2013-05-16 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-17 13:18:00, ended at 2013-05-17 14:29:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-17 14:30:00, ended at 2013-05-17 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.38 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.2 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.34 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 127 (thousand per microliter)\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Collection of venous blood by venipuncture\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Disorder of gallbladder\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-20 11:40:00, ended at 2013-05-20 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-21 13:10:00, ended at 2013-05-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-22 13:19:00, ended at 2013-05-22 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-23 13:18:00, ended at 2013-05-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Radiation treatment management, 5 treatments\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-24 00:00:00, ended at 2013-05-24 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Convalescence after radiotherapy\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 13:30:00, ended at 2013-05-24 14:09:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 14:10:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.46 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 115 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n\n### Procedure\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n- Collection of venous blood by venipuncture\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n\n### Condition\n- Acquired absence of organ\n- Hernia of anterior abdominal wall\n- Diarrhea\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-27 13:17:00, ended at 2013-05-27 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-28 13:23:00, ended at 2013-05-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-29 13:20:00, ended at 2013-05-29 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Stereoscopic X-ray guidance for localization of target volume for the delivery of radiation therapy\n- Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment session\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-06 14:48:00, ended at 2013-06-06 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-21 16:08:00, ended at 2013-06-21 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 137 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 177 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-28 12:46:00, ended at 2013-06-28 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Convalescence after radiotherapy\n- Lung field abnormal\n- Hernia of anterior abdominal wall\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-04 00:00:00, ended at 2013-07-04 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 13:39:00, ended at 2013-07-04 14:44:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Convalescence after radiotherapy\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 14:45:00, ended at 2013-07-04 15:43:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-04 15:44:00, ended at 2013-07-04 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 256 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 154 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-05 13:32:00, ended at 2013-07-05 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.26\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-23 15:51:00, ended at 2013-07-23 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 327 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-31 00:00:00, ended at 2013-07-31 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-30 16:54:00, ended at 2013-08-30 23:59:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-27 13:55:00, ended at 2013-09-27 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 229 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-30 16:00:00, ended at 2013-09-30 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Secondary malignant neoplasm of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-03 00:00:00, ended at 2013-10-03 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Convalescence after radiotherapy\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-03 14:00:00, ended at 2013-10-03 14:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- mupirocin 20 MG/ML Topical Cream, through Topical route, presumably until 2014-04-10. Instructions: by Topical route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-03 15:00:00, ended at 2013-10-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Primary diagnosis: Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-24 11:22:00, ended at 2013-12-24 13:07:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.37 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 249 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Disorder of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-24 13:08:00, ended at 2013-12-24 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of gallbladder\n- Postprocedural state finding\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-02 00:00:00, ended at 2014-01-02 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-02 14:00:00, ended at 2014-01-02 14:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-02 15:00:00, ended at 2014-01-02 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-03 12:58:00, ended at 2014-01-03 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-31 00:00:00, ended at 2014-03-31 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-01 12:19:00, ended at 2014-04-01 14:37:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.70 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 259 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of gallbladder\n- Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-01 14:38:00, ended at 2014-04-01 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of gallbladder\n- Swelling / lump finding\n- Disorder of gallbladder\n- Lung field abnormal\n- Convalescence after radiotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 13:30:00, ended at 2014-04-10 14:29:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.512\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-10 14:30:00, ended at 2014-04-10 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of gallbladder\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c36128e1b9e07a66bd3579d0f4c4af005fc6459621f425526a1bec8893722f86", "prompt_hash": "3701cabf7aa5bc4848831f993e8577a2df9f75e1121a59e0af7fe52f80a0eea6", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 5, "doc": {"person_id": 115968945, "visit_occurrence_id": 41847305, "death_date": null, "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2010-11-30 16:02:00", "visit_end_datetime": "2010-12-05 11:55:00", "visit_length_in_hours": 115.88333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n", "approximate_token_count": 2316, "patient_first_visit_date": "2008-07-01 02:25:00", "patient_last_visit_date": "2013-11-26 07:55:00", "end_obs_date": "2011-12-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 50, "cumulated_visit_num": 50, "cumulated_approximate_token_count": 16603, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d8c873cd38fa139f2c72860e17bbaed4ce73aaeda7054f32e1a655755b2f4620", "prompt_hash": "6d21513ec4b594b2d4deec6b449a47d847ad482a253fd6bc8d7c9cba33e1e6cd", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115969091, "visit_occurrence_id": 59078513, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2014-01-24 13:03:56", "visit_end_datetime": "2014-01-24 14:11:02", "visit_length_in_hours": 1.1183333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 90, "patient_first_visit_date": "2008-12-02 18:31:00", "patient_last_visit_date": "2016-03-04 14:12:40", "end_obs_date": "2015-01-24", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 17, "cumulated_visit_num": 17, "cumulated_approximate_token_count": 4183, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-02 18:31:00, ended at 2008-12-12 10:53:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 207 (picogram per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.59 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 44 (microgram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte sedimentation rate: 70 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Prothrombin time (PT): 15.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 483 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired hypothyroidism\n- Disorder of carotid artery\n- Essential hypertension\n- Postoperative infection\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-10\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-09\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-12\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2008-12-05, presumably until 2008-12-12\n- tobramycin 40 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-10\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2008-12-07, presumably until 2008-12-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-05, presumably until 2008-12-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2008-12-09, presumably until 2008-12-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-11\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2008-12-08, presumably until 2008-12-09\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2008-12-08\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2008-12-03, presumably until 2008-12-06\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-12-10, presumably until 2008-12-12\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-01-05, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: take  by mouth. 162.5mg\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 30.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-03\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-10, presumably until 2008-12-11\n- ferrous sulfate 160 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-12-02, presumably until 2008-12-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-12-11, presumably until 2008-12-11\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-02\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 4 Tabs by mouth 3 times a day. \n- labetalol hydrochloride 300 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-12-10, presumably until 2008-12-10\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-04, presumably until 2008-12-11\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2012-07-27. Instructions: take 88 mcg by mouth.\n- 6 ML gentamicin 10 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-10\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2008-12-09, presumably until 2008-12-10\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-12, presumably until 2009-12-12, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-12-02, presumably until 2008-12-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-15 00:00:00, ended at 2008-12-15 00:00:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 12:16:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n- Cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 12:17:02, ended at 2009-12-14 16:54:55\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Primary diagnosis: Cerebrovascular disease\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2012-07-27. Instructions: take by mouth daily. \n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 12:52:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-05 12:52:53, ended at 2010-07-05 15:37:49\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-13 00:00:00, ended at 2012-02-13 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 10:30:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 11:37:20, ended at 2012-02-13 12:25:34\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-27 12:45:00, ended at 2012-07-27 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-27 14:10:26, ended at 2012-07-27 14:55:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- levothyroxine sodium 0.088 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth. 1 milligram now\n- lisinopril 20 MG Oral Tablet, through Oral route, presumably until 2013-07-26. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 12:53:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 12:55:18, ended at 2013-07-26 14:23:15\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- nebivolol 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 13:03:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-02 18:31:00, ended at 2008-12-12 10:53:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.7 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 207 (picogram per milliliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.36 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 41.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.1 (microgram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.34 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.59 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 27.8 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 6.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 44 (microgram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 92 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 88.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte sedimentation rate: 70 (millimeter per hour)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 23 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Body height: 5' 2\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 190 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Prothrombin time (PT): 15.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 483 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired hypothyroidism\n- Disorder of carotid artery\n- Essential hypertension\n- Postoperative infection\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-10\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-09\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-12\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2008-12-05, presumably until 2008-12-12\n- tobramycin 40 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-10\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2008-12-07, presumably until 2008-12-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-05, presumably until 2008-12-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2008-12-09, presumably until 2008-12-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-11\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2008-12-08, presumably until 2008-12-09\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2008-12-08\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-03\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2008-12-03, presumably until 2008-12-06\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2008-12-10, presumably until 2008-12-12\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-01-05, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- aspirin 81 MG Oral Tablet, through Oral route. Instructions: take  by mouth. 162.5mg\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 30.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. \n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2008-12-03\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2008-12-06, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours. \n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-10, presumably until 2008-12-11\n- ferrous sulfate 160 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-12-02, presumably until 2008-12-09\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2008-12-11, presumably until 2008-12-11\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-12-02, presumably until 2008-12-02\n- labetalol hydrochloride 200 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2009-12-12, with quantity of 90.0, with intended 3 refill(s). Instructions: take 4 Tabs by mouth 3 times a day. \n- labetalol hydrochloride 300 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-11\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2008-12-10, presumably until 2008-12-10\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2008-12-03, presumably until 2008-12-05\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2008-12-04, presumably until 2008-12-11\n- levothyroxine sodium 0.075 MG Oral Tablet, through Oral route, started on 2008-12-03, presumably until 2012-07-27. Instructions: take 88 mcg by mouth.\n- 6 ML gentamicin 10 MG/ML Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-10\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2008-12-09, presumably until 2008-12-10\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2008-12-04, presumably until 2008-12-10\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-12, presumably until 2009-12-12, with quantity of 14.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2008-12-02, presumably until 2008-12-03\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2008-12-09, presumably until 2008-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-15 00:00:00, ended at 2008-12-15 00:00:00\nThe patient in this visit was 55 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-14 12:16:00, ended at 2009-12-14 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n- Cerebrovascular disease\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-14 12:17:02, ended at 2009-12-14 16:54:55\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral infarction\n- Primary diagnosis: Cerebrovascular disease\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- lisinopril 40 MG Oral Tablet, through Oral route, presumably until 2012-07-27. Instructions: take by mouth daily. \n- amlodipine 5 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-05 12:52:00, ended at 2010-07-05 23:59:00\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-07-05 12:52:53, ended at 2010-07-05 15:37:49\nThe patient in this visit was 56 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-02-13 00:00:00, ended at 2012-02-13 00:00:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 10:30:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 11:37:20, ended at 2012-02-13 12:25:34\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-27 12:45:00, ended at 2012-07-27 23:59:00\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-27 14:10:26, ended at 2012-07-27 14:55:07\nThe patient in this visit was 58 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- levothyroxine sodium 0.088 MG Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth. 1 milligram now\n- lisinopril 20 MG Oral Tablet, through Oral route, presumably until 2013-07-26. Instructions: take 20 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 12:53:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 12:55:18, ended at 2013-07-26 14:23:15\nThe patient in this visit was 59 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- nebivolol 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-17 00:00:00, ended at 2014-01-17 00:00:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 13:03:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 13:03:56, ended at 2014-01-24 14:11:02\nThe patient in this visit was 60 years old, Asian, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "67104261d607135d7f6cbde842c95ec7f340822c97714d80c28691b404603f87", "prompt_hash": "b697ba063b1366b6f8e8fdcc949bf2c0799ba6dae6d8dce39b062c61a1891d63", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115969160, "visit_occurrence_id": 110298957, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2017-10-13 10:57:00", "visit_end_datetime": "2017-10-13 12:46:00", "visit_length_in_hours": 1.8166666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n", "approximate_token_count": 533, "patient_first_visit_date": "2016-08-05 09:14:00", "patient_last_visit_date": "2023-01-03 00:00:00", "end_obs_date": "2018-10-13", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 90, "cumulated_visit_num": 90, "cumulated_approximate_token_count": 31036, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-05 09:14:00, ended at 2016-08-05 11:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n- Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Aortic incompetence, non-rheumatic\n- Pulmonary incompetence, non-rheumatic\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-02 00:00:00, ended at 2016-09-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-04 11:00:00, ended at 2016-09-04 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-01 00:00:00, ended at 2016-10-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-01 11:00:00, ended at 2016-10-01 11:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 00:00:00, ended at 2016-11-18 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac catheterization including coronary angiography and ventriculography (not to include Swan-Ganz catheter)\n\n### Condition\n- Congestive heart failure\n- Essential hypertension\n- Systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n- cefazolin 1000 MG Injection, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-11-18, presumably until 2016-11-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 11:50:00, ended at 2016-11-19 11:55:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.04 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 53 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 18.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Base excess in Arterial blood by calculation: -6.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 161 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 83.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 20.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Measurement of Cardiac Sampling and Pressure, Bilateral, Percutaneous Approach\n- Dilation of Left Pulmonary Artery, Percutaneous Approach\n- Percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (List separately in addition to code for primary procedure)\n- Dilation of Right Pulmonary Artery, Percutaneous Approach\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transluminal pulmonary artery balloon angioplasty; single vessel\n- Fluoroscopy of Left Pulmonary Artery using Low Osmolar Contrast\n- Fluoroscopy of Right Pulmonary Artery using Low Osmolar Contrast\n- Combined right heart catheterization and retrograde left heart catheterization, for congenital cardiac anomalies\n- Collection of blood specimen from a completely implantable venous access device\n- Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure)\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Postoperative state\n- Essential hypertension\n- Pulmonary artery stenosis\n- Adverse effect of prosthetic device\n- Obesity\n- Primary diagnosis: Tetralogy of Fallot\n- Complication of surgical procedure\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- famotidine 10 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2016-11-19, presumably until 2016-12-03, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-22 00:00:00, ended at 2016-11-22 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 100 mg by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 14:12:00, ended at 2016-12-03 15:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary perfusion imaging (eg, particulate)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 15:38:00, ended at 2016-12-03 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 07:52:00, ended at 2016-12-05 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Ectasia of thoracic aorta\n- Complication associated with device\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-11 20:54:00, ended at 2016-12-11 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 18.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.02 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 54.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 465 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n\n### Condition\n- Tetralogy of Fallot\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Postoperative state\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-13 08:48:06, ended at 2016-12-13 14:10:03\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 13:22:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Prothrombin time (PT): 77.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.53 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 8 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative state\n- Primary diagnosis: Illness\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin alfa 1000 UNT/ML Topical Solution, through Topical route, started on 2016-12-16, presumably until 2016-12-16\n- cefazolin 1000 MG Injection, started on 2016-12-16, presumably until 2016-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 06:55:00, ended at 2017-01-18 10:10:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Venous blood: 61.7 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Prothrombin time (PT): 77.7 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 9.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Body height: 5' 9.882\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Methemoglobin/Hemoglobin.total in Blood: <1.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Zinc [Mass/volume] in Blood: 86 (microgram per deciliter)\n\n### Procedure\n- Medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by physician\n- Closure of median sternotomy separation with or without debridement (separate procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Repair Right Pulmonary Artery, Open Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Repair Atrial Septum, Open Approach\n- Repair of pulmonary artery stenosis by reconstruction with patch or graft\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Unlisted pulmonary service or procedure\n- Splitting of blood or blood products, each unit\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hemodialysis procedure requiring repeated evaluation(s) with or without substantial revision of dialysis prescription\n- Controlled ventilation procedure and therapy, initiation and management\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Oxygen uptake, expired gas analysis; rest, indirect (separate procedure)\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Supplement Right Femoral Artery with Nonautologous Tissue Substitute, Open Approach\n- Repair Chest Wall, Open Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed\n- Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach\n- Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch\n- Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach\n- Bypass Right Ventricle to Pulmonary Trunk with Zooplastic Tissue, Open Approach\n- Repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Extirpation of Matter from Right Femoral Artery, Open Approach\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Release Right Lower Leg Muscle, Open Approach\n- Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Percutaneous Approach\n- Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Replacement of Thoracic Aorta, Ascending/Arch with Synthetic Substitute, Open Approach\n- Replacement of Aortic Valve with Synthetic Substitute, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Removal of Infusion Device from Upper Vein, External Approach\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Performance of Cardiac Output, Continuous\n- Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures \n- Performance of Cardiac Pacing, Continuous\n- Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, Continuous Positive Airway Pressure\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Repair Left Pulmonary Artery, Open Approach\n- Hospital discharge day management; more than 30 minutes\n- Restoration of Cardiac Rhythm, Single\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Urinary Filtration, Multiple (Deprecated)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Drainage of Left Lower Lobe Bronchus, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Repair blood vessel, direct; lower extremity\n\n### Condition\n- Acute combined systolic and diastolic heart failure\n- Aortic incompetence, non-rheumatic\n- Finding of urine output\n- Iatrogenic hypotension\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n- Obstructive sleep apnea syndrome\n- Polyneuropathy\n- Seizure\n- Supraventricular tachycardia\n- Transplanted heart valve present\n- Acute tubular necrosis\n- Bleeding\n- Disorder of pulmonary circulation\n- Drug-induced anaphylaxis\n- Low blood pressure\n- Open wound of front wall of thorax\n- Tetralogy of Fallot\n- Ulcer\n- Cardiac insufficiency following cardiac surgery\n- Compartment syndrome of lower limb\n- Gangrenous disorder\n- Iatrogenic disorder\n- Iron deficiency anemia\n- Primary diagnosis: Postoperative state\n- Postprocedural respiratory failure\n- Stenosis due to any device, implant AND/OR graft\n- Thromboembolus of artery of lower limb\n- Type 2 diabetes mellitus without complication\n- Atherosclerosis of arteries of the extremities\n- Atrial septal defect\n- Cardiac arrhythmia\n- Cardiogenic shock\n- Chronic kidney disease stage 4\n- Combined disorders of mitral, aortic and tricuspid valves\n- Congestive heart failure\n- Disseminated intravascular coagulation\n- Insomnia\n- Postoperative renal failure\n- Thromboembolism of vein\n- Acute hypoxemic respiratory failure\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Disorder of cardiovascular system\n- Heparin-induced thrombocytopenia\n- Open wound of ankle\n- Perioperative hemorrhage\n- Persistent pain following procedure\n- Renal failure syndrome\n- Disorder of bilirubin metabolism\n- Hepatosplenomegaly\n- Hypokalemia\n- Obesity\n- Rhabdomyolysis\n- Tonsil and/or adenoid hypertrophy\n- Abnormal breathing\n- Acute on chronic combined systolic and diastolic heart failure\n- Anemia in chronic kidney disease\n- Atresia of pulmonary valve\n- Blood coagulation disorder\n- Congenital heart disease\n- Dependence on enabling machine or device\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Late effect of complications of procedure\n- Malaise\n- Open wound of lower leg\n- Stricture of artery\n- Type 2 diabetes mellitus\n- Ventricular tachycardia\n- Atelectasis\n- Atrial flutter\n- Electroencephalogram abnormal\n- Hypertensive heart failure\n- Hypo-osmolality and or hyponatremia\n- Hypocalcemia\n- Open wound of knee\n- Pulmonary stenosis, non-rheumatic\n- Sepsis\n- Thoracic aortic aneurysm without rupture\n- Ventricular fibrillation\n- Autoimmune hemolytic anemia\n- Disorder of phosphorus metabolism\n- Heart failure\n- Hypervolemia\n- Pain in right foot\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (500 mg total) by mouth 2 (two) times a day.\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth 3 (three) times a day with meals.\n- 50 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-20\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2017-01-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-18\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-01-17\n- 150 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-25, presumably until 2016-12-27\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-12-23, presumably until 2016-12-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-23, presumably until 2017-01-17\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 20 mg by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth nightly as needed for sleep.\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-17\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-12-24, presumably until 2016-12-27\n- melatonin 5 MG Oral Tablet, through Oral route, started on 2016-12-26, presumably until 2016-12-26\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2016-12-19, presumably until 2016-12-19\n- folic acid, through Oral route, started on 2017-01-01, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet by mouth daily.\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2016-12-17, presumably until 2016-12-23\n- 50 ML argatroban 1 MG/ML Injection, through Intravenous route, started on 2016-12-21, presumably until 2017-01-14\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2016-12-28, presumably until 2016-12-28\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (15 mg total) by mouth daily.\n- heparin sodium, porcine 10 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-12-31, presumably until 2017-01-09\n- iodixanol, through Intravenous route, started on 2016-12-20, presumably until 2016-12-20\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-12-20, presumably until 2016-12-20\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-04, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 capsule (250 mg total) by mouth 2 (two) times a day as needed for constipation.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-23\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-01-01, presumably until 2017-01-01\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 2 tablets (8 mg total) by mouth every evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 tablets by mouth 2 (two) times a day.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth daily.\n- ketamine 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-26, presumably until 2016-12-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-09, presumably until 2017-01-09\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-06\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-01-04, presumably until 2017-01-18\n- 100 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-27\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-17\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-02, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 capsules (1,334 mg total) by mouth 3 (three) times a day with meals.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 81 mg by mouth daily.\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-07, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Inject 1 mL (4,000 Units total) into the skin Tuesday, Thursday and Saturday.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-20, presumably until 2016-12-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-12-24, presumably until 2016-12-24\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth 3 (three) times a day.\n- ketamine 100 MG/ML Injectable Solution, started on 2016-12-17, presumably until 2016-12-17\n- melatonin 1 MG/ML Oral Solution, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: 10 mLs (10 mg total) by NG-Tube route at bedtime.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2017-01-01, presumably until 2017-01-17\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-19\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2017-01-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2016-12-19, presumably until 2016-12-29\n- midazolam 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2017-01-06\n- 50 ML glucose 500 MG/ML Injection, through Intravenous route, started on 2016-12-26, presumably until 2016-12-27\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-15, presumably until 2017-01-17\n- phenylephrine hydrochloride 5 MG/ML Nasal Spray, through Nasal route, started on 2016-12-24, presumably until 2016-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of artery of lower limb\n- Primary diagnosis: Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2016-12-20, presumably until 2016-12-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Compartment syndrome of upper limb\n- Pain in toe\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thromboembolus of artery of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Edema\n- Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Thromboembolus of artery of upper limb\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compartment syndrome of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 09:09:00, ended at 2016-12-24 14:44:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized swelling, mass and lump, lower limb\n- Pain in right foot\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Pain in toe\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-02 13:00:00, ended at 2017-01-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-09 00:00:00, ended at 2017-01-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-24 13:29:49, ended at 2017-01-24 15:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-01-24 17:46:00, ended at 2017-02-13 14:30:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: -1.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Osmolality of Urine: 257 (milliosmole per kilogram)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Prothrombin time (PT): 21.9 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.13 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 110 (millimeter per hour)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 17 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Base excess in Blood by calculation: 4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.6 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 53.69 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.75 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 6.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Extraction of Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Excision of Right Tibia, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Excision of Right Lower Leg Muscle, Open Approach\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Detachment at Right Lower Leg, Mid, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Amputation, leg, through tibia and fibula; open, circular (guillotine)\n- Splitting of blood or blood products, each unit\n- Radiologic examination, chest; single view, frontal\n- Excision of Right Fibula, Open Approach\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Amputation, leg, through tibia and fibula; re-amputation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Bacterial infection due to Pseudomonas\n- Hypokalemia\n- Necrosis of amputation stump\n- Rhabdomyolysis\n- Absence of lower limb\n- Postoperative state\n- Right bundle branch block\n- Type 2 diabetes mellitus without complication\n- Acquired absence of organ\n- Complication following amputation of limb\n- Infection by methicillin sensitive Staphylococcus aureus\n- Phantom limb syndrome with pain\n- Tachycardia\n- Transplanted heart valve present\n- Complication of procedure\n- Gangrenous disorder\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Primary diagnosis: Compartment syndrome of lower limb\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Acute renal failure syndrome\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus\n- Anemia\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 500 mg by mouth\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-01-28, presumably until 2017-02-06\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2017-02-06, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 325 mg by mouth\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-02-10, presumably until 2017-02-11\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-31\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-31, presumably until 2017-02-05\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-24, presumably until 2017-02-12\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-02-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-01-29, presumably until 2017-02-05\n- sodium hypochlorite 1.25 MG/ML Topical Solution, started on 2017-01-31, presumably until 2017-02-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours\n- folic acid, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2017-02-09, presumably until 2017-02-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-01-24, presumably until 2017-02-09\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 15 mg by mouth daily\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-01-25, presumably until 2017-02-13\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-04-29, with intended 0 refill(s). Instructions: take 1 Peaslee by mouth every bedtime\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 2 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-01-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-02-05\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2017-02-06, presumably until 2017-02-11\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-02-03, presumably until 2017-06-17, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 10 mg by mouth \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-01-25, presumably until 2017-01-28\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-02-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-02-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-02-08, presumably until 2017-02-17, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-24\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1,334 mg by mouth 2 times a day\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-18, presumably until 2017-02-13, with intended 0 refill(s). Instructions: inject 4,000 Units subcutaneous (under the skin)\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-25, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-01-25, presumably until 2017-02-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-01-30, presumably until 2017-01-30\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-02-03\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-01-31, presumably until 2017-02-06\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 80 mg by mouth\n- melatonin 1 MG/ML Oral Solution, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: 10 mg\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 6 Caps by mouth 3 times a day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-06-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-12, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-01-27, presumably until 2017-02-13\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2017-01-25, presumably until 2017-01-25\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of upper leg\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Transplanted heart valve present\n- Gangrenous disorder\n- Compartment syndrome of lower limb\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-01-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- cefazolin 1000 MG Injection, started on 2017-01-25, presumably until 2017-01-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Heart failure\n- Gangrenous disorder\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- ketamine 100 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; brachial plexus\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- midazolam 1 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Compartment syndrome of lower limb\n- Peripheral vascular disease\n- Essential hypertension\n- Gangrenous disorder\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2017-02-05, presumably until 2017-02-05\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n- Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 14:52:51, ended at 2017-02-17 16:16:11\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Acute renal failure syndrome\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 16:22:24, ended at 2017-02-17 16:22:37\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of lower limb\n- Acute renal failure syndrome\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-24 15:03:43, ended at 2017-02-24 16:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 14:00:00, ended at 2017-03-17 16:45:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 54.7 (percent)\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:00:31, ended at 2017-03-17 16:34:55\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:02:20, ended at 2017-03-17 16:35:29\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart valve present\n- Electrocardiogram abnormal\n- Right bundle branch block\n- Tetralogy of Fallot\n- Postoperative state\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-07-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 16:46:00, ended at 2017-03-17 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-04-28, presumably until 2017-04-28, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-29 00:00:00, ended at 2017-04-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-29, presumably until 2018-06-04, with intended 6 refill(s). Instructions: take 1 Fleischner by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 15:04:14, ended at 2017-06-17 16:50:01\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Absence of lower limb\n- Transplanted heart valve present\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-14, with intended 3 refill(s). Instructions: Take 2 caps by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Primary diagnosis: Right lower quadrant pain\n- Injury of femoral artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-13 13:43:00, ended at 2017-08-13 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Right lower quadrant pain\n- Tetralogy of Fallot\n- Injury of femoral artery\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iothalamic acid, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-08-14, presumably until 2017-08-14\n- iothalamate, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for procedures on arteries of lower leg, including bypass graft; not otherwise specified\n\n### Condition\n- Cellulitis of groin\n- Tetralogy of Fallot\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-14, presumably until 2017-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-08-14 12:09:00, ended at 2017-08-20 11:28:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.70 (thousand per microliter)\n- Base excess in Arterial blood by calculation: -2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 21.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 48 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Prothrombin time (PT): 25.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 206.0 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Repair blood vessel, direct; lower extremity\n- Insertion of Infusion Device into Upper Vein, Percutaneous Approach\n- Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft\n- Collection of venous blood by venipuncture\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of infected graft; extremity\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Replacement of Right Femoral Artery with Autologous Tissue Substitute, Open Approach\n- Excision of Left Saphenous Vein, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Postoperative state\n- Tetralogy of Fallot\n- Traumatic or non-traumatic injury\n- Abscess of groin\n- Abscess of skin and/or subcutaneous tissue\n- Complication associated with device\n- Complication of surgical procedure\n- Infection by methicillin sensitive Staphylococcus aureus\n- Infection of amputation stump\n- Postprocedural infection\n- Absence of lower limb\n- Aneurysm of artery of lower extremity\n- Primary diagnosis: Cellulitis of groin\n- Complication following amputation of limb\n- Transplanted heart valve present\n- Acquired absence of organ\n- Localized infection of skin AND/OR subcutaneous tissue\n- Obesity\n- Obstructive sleep apnea syndrome\n- Sepsis\n- Secondary pulmonary hypertension\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-19\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2022-04-24, with intended 0 refill(s). Instructions: take 10 mg by mouth every Wednesday\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2022-04-24, with intended 1 refill(s). Instructions: take 5 mg by mouth every Monday\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-10-13, with intended 2 refill(s). Instructions: 2 g by Intravenous route every 8 hours\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-19\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-08-16, presumably until 2017-08-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-14, presumably until 2017-08-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2018-01-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day \n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-08-14, presumably until 2017-08-17\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-09-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-20, with intended 3 refill(s). Instructions: 100 mL by Intravenous route every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n\n### Condition\n- Tetralogy of Fallot\n- Cellulitis of groin\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2017-08-19, presumably until 2017-08-19\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-26 09:09:25, ended at 2017-08-26 10:59:39\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 500 mg by Swish & Swallow route\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2017-03-10, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1 Application by Topical route\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2017-08-26, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 81 mg by Swish & Swallow route\n- gabapentin 300 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-26, with intended 0 refill(s). Instructions: One qhs\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1,334 mg by Swish & Swallow route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-26 13:30:00, ended at 2017-08-26 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Laceration - injury\n- Cellulitis of groin\n- Transplanted heart valve present\n- Open wound of anterior abdominal wall\n- Injury to blood vessels of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-02 08:10:47, ended at 2017-09-02 09:04:28\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Open wound of inguinal region\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-05 00:00:00, ended at 2017-09-05 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 09:31:07, ended at 2017-09-09 10:26:49\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:19:51, ended at 2017-09-09 16:25:24\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Open wound of anterior abdominal wall\n- Tetralogy of Fallot\n- Right bundle branch block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:20:09, ended at 2017-09-09 16:25:32\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-10 09:06:39, ended at 2017-09-10 10:05:44\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abscess of groin\n- Infection by methicillin sensitive Staphylococcus aureus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-16 09:57:09, ended at 2017-09-16 11:04:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 09:52:28, ended at 2017-09-23 10:25:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 09:55:42, ended at 2017-09-30 10:51:41\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-01 10:51:35, ended at 2017-10-01 12:00:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-03 00:00:00, ended at 2017-10-03 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-05 09:14:00, ended at 2016-08-05 11:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance angiography, chest (excluding myocardium), with or without contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n- Cardiac magnetic resonance imaging for velocity flow mapping (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Rheumatic tricuspid valve regurgitation\n- Cardiomegaly\n- Aortic incompetence, non-rheumatic\n- Pulmonary incompetence, non-rheumatic\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-02 00:00:00, ended at 2016-09-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-04 11:00:00, ended at 2016-09-04 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-01 00:00:00, ended at 2016-10-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-01 11:00:00, ended at 2016-10-01 11:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-09 00:00:00, ended at 2016-10-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 00:00:00, ended at 2016-11-18 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac catheterization including coronary angiography and ventriculography (not to include Swan-Ganz catheter)\n\n### Condition\n- Congestive heart failure\n- Essential hypertension\n- Systolic heart failure\n- Type 2 diabetes mellitus without complication\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n- cefazolin 1000 MG Injection, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-11-18, presumably until 2016-11-18\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- midazolam 1 MG/ML Injectable Solution, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-18 11:50:00, ended at 2016-11-19 11:55:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.04 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 53 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 18.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Base excess in Arterial blood by calculation: -6.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 161 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Oxygen [Partial pressure] in Arterial blood: 83.3 (millimeter mercury column)\n- Bicarbonate [Moles/volume] in Specimen: 20.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.3 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Measurement of Cardiac Sampling and Pressure, Bilateral, Percutaneous Approach\n- Dilation of Left Pulmonary Artery, Percutaneous Approach\n- Percutaneous transluminal pulmonary artery balloon angioplasty; each additional vessel (List separately in addition to code for primary procedure)\n- Dilation of Right Pulmonary Artery, Percutaneous Approach\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transluminal pulmonary artery balloon angioplasty; single vessel\n- Fluoroscopy of Left Pulmonary Artery using Low Osmolar Contrast\n- Fluoroscopy of Right Pulmonary Artery using Low Osmolar Contrast\n- Combined right heart catheterization and retrograde left heart catheterization, for congenital cardiac anomalies\n- Collection of blood specimen from a completely implantable venous access device\n- Injection procedure during cardiac catheterization including imaging supervision, interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure)\n\n### Condition\n- Stenosis due to any device, implant AND/OR graft\n- Postoperative state\n- Essential hypertension\n- Pulmonary artery stenosis\n- Adverse effect of prosthetic device\n- Obesity\n- Primary diagnosis: Tetralogy of Fallot\n- Complication of surgical procedure\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- famotidine 10 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2016-11-18, presumably until 2016-11-18\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2016-11-19, presumably until 2016-12-03, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-11-19, presumably until 2017-01-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2016-11-18, presumably until 2016-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-19 00:00:00, ended at 2016-11-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-22 00:00:00, ended at 2016-11-22 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 100 mg by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 14:12:00, ended at 2016-12-03 15:37:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary perfusion imaging (eg, particulate)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-03 15:38:00, ended at 2016-12-03 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-05 00:00:00, ended at 2016-12-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-05 07:52:00, ended at 2016-12-05 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, abdomen, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Ectasia of thoracic aorta\n- Complication associated with device\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-10 00:00:00, ended at 2016-12-10 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2016-12-11, presumably until 2017-01-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-11 00:00:00, ended at 2016-12-11 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-11 20:54:00, ended at 2016-12-11 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 18.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.91 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.02 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 54.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 465 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.79 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Prothrombin time (PT): 14.0 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative cardiac complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decompression fasciotomy, leg; anterior and/or lateral, and posterior compartment(s)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n\n### Condition\n- Tetralogy of Fallot\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 00:00:00, ended at 2016-12-13 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Postoperative state\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 08:46:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-13 08:48:06, ended at 2016-12-13 14:10:03\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.882\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-13 13:22:00, ended at 2016-12-13 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Postoperative cardiac complication\n- Tetralogy of Fallot\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Prothrombin time (PT): 77.7 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.53 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Parathyrin.intact [Mass/volume] in Serum or Plasma: 8 (picogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Postoperative state\n- Primary diagnosis: Illness\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin alfa 1000 UNT/ML Topical Solution, through Topical route, started on 2016-12-16, presumably until 2016-12-16\n- cefazolin 1000 MG Injection, started on 2016-12-16, presumably until 2016-12-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-12-16 06:55:00, ended at 2017-01-18 10:10:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide [Partial pressure] in Venous blood: 61.7 (millimeter mercury column)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 153 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.4 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 39.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 9480 (unit per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 52.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 36.7 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: >4.00 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.60 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: <15 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Reticulocytes [#/volume] in Blood by Automated count: 213.9 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 59.9 (millimeter mercury column)\n- Carbon dioxide [Partial pressure] in Arterial blood: 60.1 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 34.3 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 6.05 (million per microliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 87.7 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 662 (unit per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.96 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.61 (thousand per microliter)\n- Prothrombin time (PT): 77.7 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.45 (micro-international unit per milliliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.5 (microgram per milliliter)\n- Carbon dioxide [Partial pressure] in Blood: 63.0 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 694 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Arterial blood: 9.9 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 14 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 6 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Oxygen [Partial pressure] in Blood: 50 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 774 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Fasting glucose [Mass/volume] in Serum or Plasma: 469 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.26 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 44.3 (nanogram per milliliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.40 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma: 3.8 (microgram per milliliter)\n- Body height: 5' 9.882\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: >2.50 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 1729.5 (nanogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 40 (microgram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 388 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.77 (thousand per microliter)\n- Methemoglobin/Hemoglobin.total in Blood: <1.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 97.6 (millimeter mercury column)\n- Sodium [Moles/volume] in Serum or Plasma: 154 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.54 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 38.7 (thousand per microliter)\n- Zinc [Mass/volume] in Blood: 86 (microgram per deciliter)\n\n### Procedure\n- Medical team conference with interdisciplinary team of health care professionals, patient and/or family not present, 30 minutes or more; participation by physician\n- Closure of median sternotomy separation with or without debridement (separate procedure)\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Repair Right Pulmonary Artery, Open Approach\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Repair Atrial Septum, Open Approach\n- Repair of pulmonary artery stenosis by reconstruction with patch or graft\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Unlisted pulmonary service or procedure\n- Splitting of blood or blood products, each unit\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hemodialysis procedure requiring repeated evaluation(s) with or without substantial revision of dialysis prescription\n- Controlled ventilation procedure and therapy, initiation and management\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Oxygen uptake, expired gas analysis; rest, indirect (separate procedure)\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Supplement Right Femoral Artery with Nonautologous Tissue Substitute, Open Approach\n- Repair Chest Wall, Open Approach\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Ascending aorta graft, with cardiopulmonary bypass, includes valve suspension, when performed\n- Transfusion of Nonautologous Platelets into Peripheral Vein, Percutaneous Approach\n- Repair atrial septal defect, secundum, with cardiopulmonary bypass, with or without patch\n- Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach\n- Bypass Right Ventricle to Pulmonary Trunk with Zooplastic Tissue, Open Approach\n- Repair of complex cardiac anomaly other than pulmonary atresia with ventricular septal defect by construction or replacement of conduit from right or left ventricle to pulmonary artery\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; diagnostic, with cell washing, when performed (separate procedure)\n- Extirpation of Matter from Right Femoral Artery, Open Approach\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Release Right Lower Leg Muscle, Open Approach\n- Transfusion of Nonautologous Frozen Plasma into Peripheral Vein, Percutaneous Approach\n- Replacement, aortic valve, open, with cardiopulmonary bypass; with prosthetic valve other than homograft or stentless valve\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Replacement of Thoracic Aorta, Ascending/Arch with Synthetic Substitute, Open Approach\n- Replacement of Aortic Valve with Synthetic Substitute, Open Approach\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Removal of Infusion Device from Upper Vein, External Approach\n- Introduction of Nutritional Substance into Central Vein, Percutaneous Approach\n- Performance of Cardiac Output, Continuous\n- Physical therapy evaluation: high complexity, requiring these components: A history of present problem with 3 or more personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures \n- Performance of Cardiac Pacing, Continuous\n- Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, Continuous Positive Airway Pressure\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Repair Left Pulmonary Artery, Open Approach\n- Hospital discharge day management; more than 30 minutes\n- Restoration of Cardiac Rhythm, Single\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Performance of Urinary Filtration, Multiple (Deprecated)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Drainage of Left Lower Lobe Bronchus, Via Natural or Artificial Opening Endoscopic, Diagnostic\n- Repair blood vessel, direct; lower extremity\n\n### Condition\n- Acute combined systolic and diastolic heart failure\n- Aortic incompetence, non-rheumatic\n- Finding of urine output\n- Iatrogenic hypotension\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n- Obstructive sleep apnea syndrome\n- Polyneuropathy\n- Seizure\n- Supraventricular tachycardia\n- Transplanted heart valve present\n- Acute tubular necrosis\n- Bleeding\n- Disorder of pulmonary circulation\n- Drug-induced anaphylaxis\n- Low blood pressure\n- Open wound of front wall of thorax\n- Tetralogy of Fallot\n- Ulcer\n- Cardiac insufficiency following cardiac surgery\n- Compartment syndrome of lower limb\n- Gangrenous disorder\n- Iatrogenic disorder\n- Iron deficiency anemia\n- Primary diagnosis: Postoperative state\n- Postprocedural respiratory failure\n- Stenosis due to any device, implant AND/OR graft\n- Thromboembolus of artery of lower limb\n- Type 2 diabetes mellitus without complication\n- Atherosclerosis of arteries of the extremities\n- Atrial septal defect\n- Cardiac arrhythmia\n- Cardiogenic shock\n- Chronic kidney disease stage 4\n- Combined disorders of mitral, aortic and tricuspid valves\n- Congestive heart failure\n- Disseminated intravascular coagulation\n- Insomnia\n- Postoperative renal failure\n- Thromboembolism of vein\n- Acute hypoxemic respiratory failure\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Disorder of cardiovascular system\n- Heparin-induced thrombocytopenia\n- Open wound of ankle\n- Perioperative hemorrhage\n- Persistent pain following procedure\n- Renal failure syndrome\n- Disorder of bilirubin metabolism\n- Hepatosplenomegaly\n- Hypokalemia\n- Obesity\n- Rhabdomyolysis\n- Tonsil and/or adenoid hypertrophy\n- Abnormal breathing\n- Acute on chronic combined systolic and diastolic heart failure\n- Anemia in chronic kidney disease\n- Atresia of pulmonary valve\n- Blood coagulation disorder\n- Congenital heart disease\n- Dependence on enabling machine or device\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Late effect of complications of procedure\n- Malaise\n- Open wound of lower leg\n- Stricture of artery\n- Type 2 diabetes mellitus\n- Ventricular tachycardia\n- Atelectasis\n- Atrial flutter\n- Electroencephalogram abnormal\n- Hypertensive heart failure\n- Hypo-osmolality and or hyponatremia\n- Hypocalcemia\n- Open wound of knee\n- Pulmonary stenosis, non-rheumatic\n- Sepsis\n- Thoracic aortic aneurysm without rupture\n- Ventricular fibrillation\n- Autoimmune hemolytic anemia\n- Disorder of phosphorus metabolism\n- Heart failure\n- Hypervolemia\n- Pain in right foot\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (500 mg total) by mouth 2 (two) times a day.\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (325 mg total) by mouth 3 (three) times a day with meals.\n- 50 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-20\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2017-01-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-18\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-01-07, presumably until 2017-01-17\n- 150 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-25, presumably until 2016-12-27\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-12-23, presumably until 2016-12-23\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-23, presumably until 2017-01-17\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 20 mg by mouth daily.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-26\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth nightly as needed for sleep.\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-17\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-12-24, presumably until 2016-12-27\n- melatonin 5 MG Oral Tablet, through Oral route, started on 2016-12-26, presumably until 2016-12-26\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2016-12-19, presumably until 2016-12-19\n- folic acid, through Oral route, started on 2017-01-01, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet by mouth daily.\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2016-12-17, presumably until 2016-12-23\n- 50 ML argatroban 1 MG/ML Injection, through Intravenous route, started on 2016-12-21, presumably until 2017-01-14\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2016-12-28, presumably until 2016-12-28\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (15 mg total) by mouth daily.\n- heparin sodium, porcine 10 UNT/ML Prefilled Syringe, through Intravenous route, started on 2016-12-31, presumably until 2017-01-09\n- iodixanol, through Intravenous route, started on 2016-12-20, presumably until 2016-12-20\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2016-12-17\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2016-12-20, presumably until 2016-12-20\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-04, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 capsule (250 mg total) by mouth 2 (two) times a day as needed for constipation.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-18\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-23\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2016-12-30, presumably until 2017-01-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-01-01, presumably until 2017-01-01\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 2 tablets (8 mg total) by mouth every evening.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-09, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 tablets by mouth 2 (two) times a day.\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take by mouth daily.\n- ketamine 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-26, presumably until 2016-12-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-09, presumably until 2017-01-09\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2016-12-31, presumably until 2017-01-06\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-01-04, presumably until 2017-01-18\n- 100 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2016-12-24, presumably until 2016-12-27\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-16, presumably until 2016-12-17\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-02, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 2 capsules (1,334 mg total) by mouth 3 (three) times a day with meals.\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 81 mg by mouth daily.\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-07, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Inject 1 mL (4,000 Units total) into the skin Tuesday, Thursday and Saturday.\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2016-12-19, presumably until 2016-12-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2016-12-20, presumably until 2016-12-24\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2016-12-17, presumably until 2017-01-14\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2016-12-24, presumably until 2016-12-24\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-01-17, with intended 0 refill(s). Instructions: Take 1 tablet (80 mg total) by mouth 3 (three) times a day.\n- ketamine 100 MG/ML Injectable Solution, started on 2016-12-17, presumably until 2016-12-17\n- melatonin 1 MG/ML Oral Solution, through Oral route, started on 2016-12-27, presumably until 2017-01-17, with intended 0 refill(s). Instructions: 10 mLs (10 mg total) by NG-Tube route at bedtime.\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2017-01-01, presumably until 2017-01-17\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 capsule (100 mg total) by mouth 2 (two) times a day.\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2016-12-18, presumably until 2016-12-19\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2017-01-04, presumably until 2017-01-06\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-10, presumably until 2017-01-18, with intended 0 refill(s). Instructions: Take 1 tablet (5 mg total) by mouth every 4 (four) hours as needed.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2016-12-19, presumably until 2016-12-29\n- midazolam 1 MG/ML Injectable Solution, through Intravenous route, started on 2016-12-17, presumably until 2017-01-06\n- 50 ML glucose 500 MG/ML Injection, through Intravenous route, started on 2016-12-26, presumably until 2016-12-27\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-15, presumably until 2017-01-17\n- phenylephrine hydrochloride 5 MG/ML Nasal Spray, through Nasal route, started on 2016-12-24, presumably until 2016-12-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atherosclerosis of artery of lower limb\n- Primary diagnosis: Intermittent claudication of right lower limb co-occurrent and due to atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-20 00:00:00, ended at 2016-12-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2016-12-20, presumably until 2016-12-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Compartment syndrome of upper limb\n- Pain in toe\n- Pain in right foot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thromboembolus of artery of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Edema\n- Localized swelling, mass and lump, lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n\n### Condition\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Thromboembolus of artery of upper limb\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compartment syndrome of upper limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-12-24 00:00:00, ended at 2016-12-24 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-24 09:09:00, ended at 2016-12-24 14:44:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized swelling, mass and lump, lower limb\n- Pain in right foot\n- Intermittent claudication due to atherosclerosis of artery of limb\n- Pain in toe\n- Atherosclerosis of arteries of the extremities\n- Thrombophlebitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-02 00:00:00, ended at 2017-01-02 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-02 13:00:00, ended at 2017-01-02 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure\n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-09 00:00:00, ended at 2017-01-09 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-20 00:00:00, ended at 2017-01-20 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-24 13:29:49, ended at 2017-01-24 15:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-01-24 17:46:00, ended at 2017-02-13 14:30:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Base excess in Arterial blood by calculation: -1.5 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.88 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.25 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Osmolality of Urine: 257 (milliosmole per kilogram)\n- Oxygen [Partial pressure] in Arterial blood: 231.0 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Prothrombin time (PT): 21.9 (second)\n- C reactive protein [Mass/volume] in Serum or Plasma: 21.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.13 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 110 (millimeter per hour)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 17 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 9.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.5 (second)\n- Neutrophils [#/volume] in Blood by Automated count: 7.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Base excess in Blood by calculation: 4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.6 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 53.69 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.75 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 6.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.9 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 82 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.6 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 4.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); first 20 sq cm or less\n- Debridement, muscle and/or fascia (includes epidermis, dermis, and subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Extraction of Right Lower Leg Subcutaneous Tissue and Fascia, Open Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Excision of Right Tibia, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Excision of Right Lower Leg Muscle, Open Approach\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Detachment at Right Lower Leg, Mid, Open Approach\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); concurrent infusion (List separately in addition to code for primary procedure)\n- Amputation, leg, through tibia and fibula; open, circular (guillotine)\n- Splitting of blood or blood products, each unit\n- Radiologic examination, chest; single view, frontal\n- Excision of Right Fibula, Open Approach\n- Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, Continuous Positive Airway Pressure\n- Amputation, leg, through tibia and fibula; re-amputation\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Bacterial infection due to Pseudomonas\n- Hypokalemia\n- Necrosis of amputation stump\n- Rhabdomyolysis\n- Absence of lower limb\n- Postoperative state\n- Right bundle branch block\n- Type 2 diabetes mellitus without complication\n- Acquired absence of organ\n- Complication following amputation of limb\n- Infection by methicillin sensitive Staphylococcus aureus\n- Phantom limb syndrome with pain\n- Tachycardia\n- Transplanted heart valve present\n- Complication of procedure\n- Gangrenous disorder\n- Hypo-osmolality and or hyponatremia\n- Obesity\n- Primary diagnosis: Compartment syndrome of lower limb\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Cardiomegaly\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Acute renal failure syndrome\n- Obstructive sleep apnea syndrome\n- Type 2 diabetes mellitus\n- Anemia\n\n### Drug\n- 1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 500 mg by mouth\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-01-28, presumably until 2017-02-06\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2017-02-06, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 325 mg by mouth\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-02-10, presumably until 2017-02-11\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-31\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-31, presumably until 2017-02-05\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-29\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-24, presumably until 2017-02-12\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- naloxone hydrochloride 0.4 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-02-05\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2017-01-29, presumably until 2017-02-05\n- sodium hypochlorite 1.25 MG/ML Topical Solution, started on 2017-01-31, presumably until 2017-02-11\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours\n- folic acid, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2017-02-09, presumably until 2017-02-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-01-24, presumably until 2017-02-09\n- oxycodone hydrochloride 15 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 15 mg by mouth daily\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-01-25, presumably until 2017-02-13\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-04-29, with intended 0 refill(s). Instructions: take 1 Peaslee by mouth every bedtime\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2017-02-07, presumably until 2017-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 2 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-01-27, presumably until 2017-01-27\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 250 mg by mouth 2 times a day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-02-05\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2017-02-06, presumably until 2017-02-11\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-02-03, presumably until 2017-06-17, with intended 0 refill(s). Instructions: by Topical route 2 times a day\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 10 mg by mouth \n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 2 Tabs by mouth\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2017-01-25, presumably until 2017-01-28\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-01-29, presumably until 2017-02-13\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-02-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-02-08, presumably until 2017-02-17, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily as needed\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-01-24, presumably until 2017-01-24\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 1,334 mg by mouth 2 times a day\n- 1 ML epoetin alfa 4000 UNT/ML Injection, through Subcutaneous route, started on 2017-01-18, presumably until 2017-02-13, with intended 0 refill(s). Instructions: inject 4,000 Units subcutaneous (under the skin)\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-25, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-01-25, presumably until 2017-02-07\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2017-01-30, presumably until 2017-01-30\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-02-03\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-01-31, presumably until 2017-02-06\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: take 80 mg by mouth\n- melatonin 1 MG/ML Oral Solution, started on 2017-01-17, presumably until 2017-02-13, with intended 0 refill(s). Instructions: 10 mg\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-03-17, with intended 0 refill(s). Instructions: take 6 Caps by mouth 3 times a day\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-06-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-12, presumably until 2017-08-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-01-27, presumably until 2017-02-13\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-02-01, presumably until 2017-02-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2017-01-25, presumably until 2017-01-25\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-25 00:00:00, ended at 2017-01-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for all procedures on nerves, muscles, tendons, fascia, and bursae of upper leg\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Transplanted heart valve present\n- Gangrenous disorder\n- Compartment syndrome of lower limb\n- Tetralogy of Fallot\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-25, presumably until 2017-01-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- cefazolin 1000 MG Injection, started on 2017-01-25, presumably until 2017-01-25\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-25, presumably until 2017-01-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Heart failure\n- Gangrenous disorder\n- Transplanted heart valve present\n- Compartment syndrome of lower limb\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-01-29, presumably until 2017-01-29\n- ketamine 100 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-01-29 00:00:00, ended at 2017-01-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; brachial plexus\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-01-29, presumably until 2017-01-29\n- midazolam 1 MG/ML Injectable Solution, started on 2017-01-29, presumably until 2017-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for open procedures on bones of lower leg, ankle, and foot; radical resection (including below knee amputation)\n\n### Condition\n- Compartment syndrome of lower limb\n- Peripheral vascular disease\n- Essential hypertension\n- Gangrenous disorder\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2017-02-05, presumably until 2017-02-05\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2017-02-05, presumably until 2017-02-05\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-05 00:00:00, ended at 2017-02-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s), anesthetic agent(s) and/or steroid; femoral nerve\n- Injection(s), anesthetic agent(s) and/or steroid; sciatic nerve\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-02-05, presumably until 2017-02-05\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-05, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 14:52:51, ended at 2017-02-17 16:16:11\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Acute renal failure syndrome\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-17 16:22:24, ended at 2017-02-17 16:22:37\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of lower limb\n- Acute renal failure syndrome\n- Primary diagnosis: Acquired absence of organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-24 15:03:43, ended at 2017-02-24 16:26:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 14:00:00, ended at 2017-03-17 16:45:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 54.7 (percent)\n\n### Procedure\n- Transthoracic echocardiography for congenital cardiac anomalies; complete\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:00:31, ended at 2017-03-17 16:34:55\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired absence of organ\n- Primary diagnosis: Absence of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-17 15:02:20, ended at 2017-03-17 16:35:29\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart valve present\n- Electrocardiogram abnormal\n- Right bundle branch block\n- Tetralogy of Fallot\n- Postoperative state\n\n### Drug\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-03-17, presumably until 2017-07-17, with intended 3 refill(s). Instructions: take 2 Caps by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-17 16:46:00, ended at 2017-03-17 23:59:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.48 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.85 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.83 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 336 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.19 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-04-28, presumably until 2017-04-28, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-29 00:00:00, ended at 2017-04-29 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-29, presumably until 2018-06-04, with intended 6 refill(s). Instructions: take 1 Fleischner by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-17 15:04:14, ended at 2017-06-17 16:50:01\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acquired absence of organ\n- Absence of lower limb\n- Transplanted heart valve present\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Primary diagnosis: Compartment syndrome of lower limb\n\n### Drug\n- gabapentin 100 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-14, with intended 3 refill(s). Instructions: Take 2 caps by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-12 00:00:00, ended at 2017-08-12 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Tetralogy of Fallot\n- Primary diagnosis: Right lower quadrant pain\n- Injury of femoral artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-13 13:43:00, ended at 2017-08-13 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Right lower quadrant pain\n- Tetralogy of Fallot\n- Injury of femoral artery\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iothalamic acid, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-08-14, presumably until 2017-08-14\n- iothalamate, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 500 ML heparin sodium, porcine 2 UNT/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-14 00:00:00, ended at 2017-08-14 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Anesthesia for procedures on arteries of lower leg, including bypass graft; not otherwise specified\n\n### Condition\n- Cellulitis of groin\n- Tetralogy of Fallot\n- Essential hypertension\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-14, presumably until 2017-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-14, presumably until 2017-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-08-14 12:09:00, ended at 2017-08-20 11:28:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.70 (thousand per microliter)\n- Base excess in Arterial blood by calculation: -2.5 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 21.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Glucose [Mass/volume] in Blood: 167 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 325 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 20.9 (microgram per milliliter)\n- Base excess in Blood by calculation: 3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 48 (millimeter per hour)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Prothrombin time (PT): 25.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 34.1 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 18.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.90 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.9 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 206.0 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Repair blood vessel, direct; lower extremity\n- Insertion of Infusion Device into Upper Vein, Percutaneous Approach\n- Revision, femoral anastomosis of synthetic arterial bypass graft in groin, open; with autogenous vein patch graft\n- Collection of venous blood by venipuncture\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Computed tomographic angiography, abdominal aorta and bilateral iliofemoral lower extremity runoff, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Excision of infected graft; extremity\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Replacement of Right Femoral Artery with Autologous Tissue Substitute, Open Approach\n- Excision of Left Saphenous Vein, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Postoperative state\n- Tetralogy of Fallot\n- Traumatic or non-traumatic injury\n- Abscess of groin\n- Abscess of skin and/or subcutaneous tissue\n- Complication associated with device\n- Complication of surgical procedure\n- Infection by methicillin sensitive Staphylococcus aureus\n- Infection of amputation stump\n- Postprocedural infection\n- Absence of lower limb\n- Aneurysm of artery of lower extremity\n- Primary diagnosis: Cellulitis of groin\n- Complication following amputation of limb\n- Transplanted heart valve present\n- Acquired absence of organ\n- Localized infection of skin AND/OR subcutaneous tissue\n- Obesity\n- Obstructive sleep apnea syndrome\n- Sepsis\n- Secondary pulmonary hypertension\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-19\n- warfarin sodium 10 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2022-04-24, with intended 0 refill(s). Instructions: take 10 mg by mouth every Wednesday\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2022-04-24, with intended 1 refill(s). Instructions: take 5 mg by mouth every Monday\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-08-17, presumably until 2017-08-17\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-10-13, with intended 2 refill(s). Instructions: 2 g by Intravenous route every 8 hours\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-08-15, presumably until 2017-08-19\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-08-16, presumably until 2017-08-18\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-14, presumably until 2017-08-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-08-15, presumably until 2017-08-17\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-14, presumably until 2017-08-14\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2018-01-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day \n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-08-14, presumably until 2017-08-17\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-08-20\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-08-15, presumably until 2017-09-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-08-17, presumably until 2017-08-20, with intended 3 refill(s). Instructions: 100 mL by Intravenous route every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n\n### Condition\n- Tetralogy of Fallot\n- Cellulitis of groin\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2017-08-19, presumably until 2017-08-19\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-19, presumably until 2017-08-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-26 09:09:25, ended at 2017-08-26 10:59:39\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 500 mg by Swish & Swallow route\n- triamcinolone acetonide 0.001 MG/MG Topical Ointment, through Topical route, started on 2017-03-10, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1 Application by Topical route\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2017-08-26, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 81 mg by Swish & Swallow route\n- gabapentin 300 MG Oral Capsule, started on 2017-07-17, presumably until 2017-08-26, with intended 0 refill(s). Instructions: One qhs\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2017-01-17, presumably until 2017-09-09, with intended 0 refill(s). Instructions: 1,334 mg by Swish & Swallow route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-26 13:30:00, ended at 2017-08-26 23:59:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Laceration - injury\n- Cellulitis of groin\n- Transplanted heart valve present\n- Open wound of anterior abdominal wall\n- Injury to blood vessels of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-02 08:10:47, ended at 2017-09-02 09:04:28\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Negative pressure wound therapy (eg, vacuum assisted drainage collection), utilizing durable medical equipment (DME), including topical application(s), wound assessment, and instruction(s) for ongoing care, per session; total wound(s) surface area less th\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Open wound of inguinal region\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-05 00:00:00, ended at 2017-09-05 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 09:31:07, ended at 2017-09-09 10:26:49\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:19:51, ended at 2017-09-09 16:25:24\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Open wound of anterior abdominal wall\n- Tetralogy of Fallot\n- Right bundle branch block\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-09 12:20:09, ended at 2017-09-09 16:25:32\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tetralogy of Fallot\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-10 09:06:39, ended at 2017-09-10 10:05:44\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abscess of groin\n- Infection by methicillin sensitive Staphylococcus aureus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-16 09:57:09, ended at 2017-09-16 11:04:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less\n\n### Condition\n- Primary diagnosis: Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-23 09:52:28, ended at 2017-09-23 10:25:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Debridement (eg, high pressure waterjet with/without suction, sharp selective debridement with scissors, scalpel and forceps), open wound, (eg, fibrin, devitalized epidermis and/or dermis, exudate, debris, biofilm), including topical application(s), wound\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-30 09:55:42, ended at 2017-09-30 10:51:41\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Late effect of open wound of head, neck and trunk\n- Open wound of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-01 10:51:35, ended at 2017-10-01 12:00:55\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-03 00:00:00, ended at 2017-10-03 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Primary diagnosis: Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-13 10:57:00, ended at 2017-10-13 12:46:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 5.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.2 (percent)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n- Body height: 5' 10\" (inch (US))\n- Eosinophils [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 185 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 86.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- MCH [Entitic mass] by Automated count: 28.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.93 (thousand per microliter)\n\n### Procedure\n- Removal of Infusion Device from Great Vessel, External Approach\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Tetralogy of Fallot\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2017-10-13, presumably until 2017-10-13\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "6608c77a8df64af106484f8202d60c2955aca5e016266c3b6f3901d4f43c855d", "prompt_hash": "ed6d0bc8621dcfb051150a0d6c139f6e1131fed593d2fa96da6ef3ed3ed4d784", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 8, "doc": {"person_id": 115969703, "visit_occurrence_id": 83107325, "death_date": "2017-06-24", "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-02-19 09:00:00", "visit_end_datetime": "2016-02-19 23:59:00", "visit_length_in_hours": 14.983333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 922, "patient_first_visit_date": "2011-10-29 00:00:00", "patient_last_visit_date": "2017-06-18 10:23:00", "end_obs_date": "2017-02-18", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "recurrent", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 137, "cumulated_visit_num": 137, "cumulated_approximate_token_count": 61094, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-29 00:00:00, ended at 2011-10-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-29 11:11:50, ended at 2011-10-29 12:34:54\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-26 00:00:00, ended at 2013-04-26 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-04-26, presumably until 2013-04-26, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-02, presumably until 2013-09-02, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-09 00:00:00, ended at 2013-09-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2013-09-09, presumably until 2015-06-25, with intended 10 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-09 09:23:43, ended at 2013-11-09 10:40:25\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Cardiac arrhythmia\n- Contracture of palmar fascia\n- Disorder of transplanted kidney\n- Left bundle branch hemiblock\n- Primary diagnosis: Transplanted kidney present\n- Electrocardiogram abnormal\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Inflammatory dermatosis\n- Tachycardia\n\n### Drug\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2015-06-25. Instructions: inject 15 Units subcutaneous (under the skin) every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-09 10:44:00, ended at 2013-11-09 11:23:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 240 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 188 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 5.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Tachycardia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-11 00:00:00, ended at 2013-11-11 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-14 00:00:00, ended at 2013-11-14 00:00:00\nThe patient in this visit was 65 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Kidney lesion\n- Transplanted kidney present\n- Primary diagnosis: Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-23 13:54:00, ended at 2013-11-23 21:40:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n- aPTT in Platelet poor plasma by Coagulation assay: 30.3 (second)\n- Prothrombin time (PT): 12.4 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Renal biopsy; percutaneous, by trocar or needle\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Closed [percutaneous] [needle] biopsy of kidney\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Hydronephrosis\n- Nephrosclerosis\n- Primary diagnosis: Nephrotic syndrome\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Disorder of calcium metabolism\n- Renal function tests abnormal\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-23, presumably until 2013-11-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-23 14:44:14, ended at 2013-11-23 17:25:06\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-02 00:00:00, ended at 2013-12-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-14 00:00:00, ended at 2013-12-14 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acquired renal cystic disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-16 00:00:00, ended at 2013-12-16 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-21 00:00:00, ended at 2013-12-21 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-21 11:29:00, ended at 2013-12-21 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-23 13:32:00, ended at 2013-12-23 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions\n\n### Condition\n- Acquired renal cystic disease\n- Disorder of kidney and/or ureter\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:37:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.12 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-23 10:29:18, ended at 2014-01-23 11:31:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gout\n- Membranous glomerulonephritis\n- Secondary diabetes mellitus\n- Hyperlipidemia\n- Nephrotic syndrome\n- Kidney lesion\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2015-01-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. Take 1 PO every HS\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2014-01-23, presumably until 2014-05-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-07 14:09:59, ended at 2014-02-07 15:55:57\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Contracture of palmar fascia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-02 08:47:31, ended at 2014-03-02 09:21:27\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Left bundle branch hemiblock\n- Electrocardiogram abnormal\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-02 09:22:00, ended at 2014-03-02 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Pre-surgery evaluation\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-04 09:26:00, ended at 2014-05-04 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.4 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 29.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 238 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Peripheral neuritis\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-09, with intended 0 refill(s). Instructions: Take one cap at night. May increase to 3 capsules at night.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-09 00:00:00, ended at 2014-05-09 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n- Primary diagnosis: Low back pain\n- Altered sensation of skin\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2014-05-09, presumably until 2014-05-17, with intended 1 refill(s). Instructions: Take one capsule by mouth at night. Increase by one capsule, daily, up to 3 capsules, 3 times per day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 09:05:33, ended at 2014-05-09 10:51:26\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral neuritis\n- Altered sensation of skin\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-17 09:55:07, ended at 2014-05-17 11:19:08\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Contracture of palmar fascia\n- Essential hypertension\n- Transplanted kidney present\n- Gastroesophageal reflux disease\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2015-06-25. Instructions: take 300 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-19 14:58:00, ended at 2014-05-19 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Altered sensation of skin\n- Low back pain\n- Displacement of lumbar intervertebral disc without myelopathy\n- Lumbosacral spondylosis without myelopathy\n- Spinal stenosis of lumbar region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-23 00:00:00, ended at 2014-05-23 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-31 00:00:00, ended at 2014-05-31 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Acquired renal cystic disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-06-02 00:00:00, ended at 2014-06-02 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-06-02, presumably until 2014-06-02\n- iohexol, through Intravenous route, started on 2014-06-02, presumably until 2014-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 14:19:00, ended at 2014-06-02 15:55:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Other x-ray of lumbosacral spine\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, each additional level (List separately in addition to code for primary procedure)\n- Injection of steroid\n- Injection of other agent into spinal canal\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Displacement of lumbar intervertebral disc without myelopathy\n- Gastroesophageal reflux disease\n- Transplanted kidney present\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:12, ended at 2014-06-02 15:42:38\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-02 15:28:13, ended at 2014-06-02 15:42:39\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, spine, single view, specify level\n\n### Condition\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 09:17:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 108 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.00 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.6 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.73 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-07-10 00:00:00, ended at 2014-07-10 00:00:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n- Primary diagnosis: Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-07-10 15:41:35, ended at 2014-07-10 16:54:36\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Displacement of lumbar intervertebral disc without myelopathy\n- Peripheral neuritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-16 00:00:00, ended at 2015-03-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Albumin [Mass/volume] in Urine: 12200 (milligram per liter)\n- Creatinine [Mass/volume] in Urine: 133.30 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 11 - 20 (per high power field)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 9152 (milligram per gram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-06-24 23:33:00, ended at 2015-07-03 14:50:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 23.7 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 82 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.0 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 114 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.0 (ratio)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 756 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: 0.8 (microgram per milliliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Adenosine deaminase [Enzymatic activity/volume] in Peritoneal fluid: 3.3 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.1 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 116 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 35 (percent)\n- Protein [Mass/volume] in Urine: 5857 (milligram per volume)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.1 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Prothrombin time (PT): 14.6 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 83.4 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Neutrophils [#/volume] in Blood by Automated count: 3.56 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.22 (milligram per milligram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 269 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Base excess in Blood by calculation: -2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 161 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.2 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 23 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n\n### Procedure\n- Closed [percutaneous] [needle] biopsy of kidney\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Renal biopsy; percutaneous, by trocar or needle\n- Plasmapheresis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Insertion of graft for vascular access\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Abdominal paracentesis\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Hospital discharge day management; more than 30 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Collection of venous blood by venipuncture\n\n### Condition\n- Immune defect\n- Nephrosclerosis\n- Breathing painful\n- Disorder of transplanted kidney\n- Essential hypertension\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Nephrotic syndrome\n- Non-infectious disorder of lymphatics\n- Right lower quadrant pain\n- Acute renal papillary necrosis with renal failure\n- Disorder of calcium metabolism\n- Flatulence, eructation and gas pain\n- Nephrotic syndrome with membranous glomerulonephritis\n- Transplanted kidney present\n- Atherosclerosis of aorta\n- Disorder affecting transplanted structure\n- Disorder of plasma protein metabolism\n- Late effect of medical and surgical care complication\n- Edema\n- Hypervolemia\n- Tobacco dependence syndrome\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cardiac arrhythmia\n- Hydronephrosis\n- Primary diagnosis: Membranous glomerulonephritis\n- Gout\n- Hyperlipidemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-06-14, presumably until 2015-08-09, with intended 11 refill(s). Instructions: take 750 mg by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-01, presumably until 2015-07-01\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-06-27, presumably until 2015-07-03\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 2.5 mg by mouth 2 times a day\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-06-25, presumably until 2015-06-27\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-06-18, presumably until 2015-08-10, with intended 2 refill(s). Instructions: take 1 mg by mouth as directed Take 1 cap (1 mg) in the morning and 2 caps (2 mg) in the evenings daily.\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-03, presumably until 2015-07-12, with intended 0 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-08-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 3 refill(s). Instructions: take 30 mg by mouth every morning\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-06-26, presumably until 2015-06-26\n- 24 HR nifedipine 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-15, presumably until 2015-07-03, with intended 0 refill(s). Instructions: take 30 mg by mouth 2 times a day\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-06-28, presumably until 2015-06-28\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-07-03, presumably until 2015-07-26, with intended 1 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-07-03, with intended 1 refill(s). Instructions: take 20 mg by mouth every morning\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-06-25, presumably until 2015-06-27\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-04-21, presumably until 2015-08-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-06-25, presumably until 2015-07-02\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-06-25, presumably until 2015-07-03\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-06-30\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-06-25, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-06-26, presumably until 2015-06-26\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2015-06-30, presumably until 2015-10-30, with intended 2 refill(s). Instructions: instill 1 Drop to both eyes 2 times a day as needed\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2015-06-25, presumably until 2015-06-25\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-06-28, presumably until 2015-07-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-07-04, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-09-28, presumably until 2015-07-16, with intended 2 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-06-29, presumably until 2015-07-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2013-11-25, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 81 mg by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-30 12:30:00, ended at 2015-06-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 355 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-01 13:00:00, ended at 2015-07-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 313 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-02 10:48:00, ended at 2015-07-02 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 320 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-07-02, presumably until 2015-07-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-04 12:53:00, ended at 2015-07-04 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.94 (million per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 260 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.42 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 163 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-04, presumably until 2015-07-04\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-04, presumably until 2015-07-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-05 12:49:00, ended at 2015-07-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.30 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-05, presumably until 2015-07-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-05, presumably until 2015-07-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-05, presumably until 2015-07-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-06 00:00:00, ended at 2015-07-06 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-06 12:52:00, ended at 2015-07-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 90 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.57 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 64.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 139 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Transplanted kidney present\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-06, presumably until 2015-07-06\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-06, presumably until 2015-07-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-06, presumably until 2015-07-06\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-07-05, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth daily Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-09 00:00:00, ended at 2015-07-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Protein [Mass/volume] in Urine: 26531 (milligram per volume)\n- Creatinine [Mass/volume] in Urine: 44.4 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1255 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-09 12:55:00, ended at 2015-07-09 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 108.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 2.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-09, presumably until 2015-07-09\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-09, presumably until 2015-07-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-10 00:00:00, ended at 2015-07-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-10 13:00:00, ended at 2015-07-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 148 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.59 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Transplanted kidney present\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-10, presumably until 2015-07-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-10, presumably until 2015-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-12 00:00:00, ended at 2015-07-12 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-12, presumably until 2015-07-22, with intended 3 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 11:00:00, ended at 2015-07-12 12:26:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder affecting transplanted structure\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Acquired renal cystic disease\n- Late effect of medical and surgical care complication\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-12 11:33:26, ended at 2015-07-12 12:22:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Renovascular hypertension\n- Nephrotic syndrome\n- Primary diagnosis: Transplanted kidney present\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Tobacco dependence syndrome\n- Hyperlipidemia\n- Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-12 12:27:00, ended at 2015-07-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 30.62 (milligram per milligram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 81.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 16.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 14.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 2483 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-16, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-16 00:00:00, ended at 2015-07-16 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Constipation\n\n### Drug\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-07-16, presumably until 2015-07-16, with intended 2 refill(s). Instructions: take 1 Packet by mouth One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-16 10:37:00, ended at 2015-07-16 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 286 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.4 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-16, presumably until 2015-07-16\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-16, presumably until 2015-07-16\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-16, presumably until 2015-07-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-17 13:30:00, ended at 2015-07-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 117 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-17, presumably until 2015-07-17\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-17, presumably until 2015-07-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-17, presumably until 2015-07-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-18 00:00:00, ended at 2015-07-18 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Constipation\n- Primary diagnosis: Kidney lesion\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-18, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-18 13:30:00, ended at 2015-07-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.50 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.14 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 204 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-18, presumably until 2015-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-18, presumably until 2015-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 1 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-20, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-07-20, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-20 00:00:00, ended at 2015-07-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-08, with intended 6 refill(s). Instructions: inject 9 Units subcutaneous (under the skin) 3 times a day before meals\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-20, presumably until 2015-07-24, with intended 0 refill(s). Instructions: take 10 g by mouth 3 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-07-20, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 26 Units subcutaneous (under the skin) every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-20 13:00:00, ended at 2015-07-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 114 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 195 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-07-20, presumably until 2015-07-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-07-20, presumably until 2015-07-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-20, presumably until 2015-07-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-23 13:30:00, ended at 2015-07-23 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 101 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.01 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.2 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 271 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.51 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-23, presumably until 2015-07-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-24 00:00:00, ended at 2015-07-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- lactulose 10000 MG Powder for Oral Solution, through Oral route, started on 2015-07-24, presumably until 2015-07-26, with intended 2 refill(s). Instructions: take 10 g by mouth 3 times a day X 2 days OR AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-25 13:30:00, ended at 2015-07-25 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-25, presumably until 2015-07-25\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-25, presumably until 2015-07-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 1 refill(s). Instructions: take 4 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-07-26 00:00:00, ended at 2015-07-26 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-07-26, presumably until 2015-08-09, with intended 3 refill(s). Instructions: take 15 mL by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-26 10:02:29, ended at 2015-07-26 11:33:18\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Peripheral neuritis\n- Membranous glomerulonephritis\n- Hyperlipidemia\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n- Primary diagnosis: Transplanted kidney present\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Spinal stenosis of lumbar region\n- Renovascular hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-27 08:37:00, ended at 2015-07-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.82 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-27, presumably until 2015-07-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-27, presumably until 2015-07-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-30 13:30:00, ended at 2015-07-30 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.69 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 212 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 106 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 157 (milligram per deciliter)\n- Prothrombin time (PT): 14.0 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-07-30, presumably until 2015-07-30\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-07-30, presumably until 2015-07-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 08:25:00, ended at 2015-08-01 08:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Creatinine [Mass/volume] in Urine: 79.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 72 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.87 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1540 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.27 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.27 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Kidney lesion\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-01 09:00:00, ended at 2015-08-01 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 214 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-01, presumably until 2015-08-01\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-01, presumably until 2015-08-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-01, presumably until 2015-08-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-03 09:00:00, ended at 2015-08-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 320 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-03, presumably until 2015-08-03\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-03, presumably until 2015-08-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 08:47:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1189 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 66.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 215 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 17.99 (milligram per milligram)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-06, presumably until 2015-08-06\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-06, presumably until 2015-08-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-08 00:00:00, ended at 2015-08-08 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-08, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-08 08:48:00, ended at 2015-08-08 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.28 (milligram per milligram)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 153 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 121 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.81 (million per microliter)\n- MCV [Entitic volume] by Automated count: 91.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.30 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1639 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 3.0 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-08, presumably until 2015-08-08\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-08, presumably until 2015-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-09 00:00:00, ended at 2015-08-09 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Transplanted kidney present\n- Membranous glomerulonephritis\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-09, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-03-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-09-19, with intended 11 refill(s). Instructions: take 4 Tabs by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2016-05-14, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2017-06-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-10, presumably until 2015-09-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 10:25:28, ended at 2015-08-09 11:35:20\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nephrotic syndrome\n- Disorder of phosphorus metabolism\n- Tobacco dependence syndrome\n- Transplanted kidney present\n- Chronic kidney disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Kidney lesion\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-09, presumably until 2015-08-09, with intended 6 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-09, presumably until 2015-08-09, with intended 9 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take as needed for swelling in legs\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-09 15:19:02, ended at 2015-08-09 16:16:35\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.173\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-06-14, presumably until 2015-08-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily \n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2015-08-07, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 30 mg by mouth daily \n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every bedtime \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-10, presumably until 2015-08-17, with intended 11 refill(s). Instructions: Take 1mg QAM and 2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-10 00:00:00, ended at 2015-08-10 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-10 08:30:00, ended at 2015-08-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.23 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 112 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 166 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 126 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-10, presumably until 2015-08-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-10, presumably until 2015-08-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-13 08:29:00, ended at 2015-08-13 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.95 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 111 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1417 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 216 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.38 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 16.50 (milligram per milligram)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Nephrotic syndrome\n- Membranous glomerulonephritis\n- Disorder of phosphorus metabolism\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-13, presumably until 2015-08-13\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-13, presumably until 2015-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-15 08:23:00, ended at 2015-08-15 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.27 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 91.9 (femtoliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 172 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Primary diagnosis: Membranous glomerulonephritis\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-15, presumably until 2015-08-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-15, presumably until 2015-08-15\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-15, presumably until 2015-08-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-08-17 00:00:00, ended at 2015-08-17 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-08-17, presumably until 2015-10-06, with intended 11 refill(s). Instructions: Take 2mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-17 08:13:00, ended at 2015-08-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 70.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 65 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 183 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.88 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 96 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.9 (percent)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-17, presumably until 2015-08-17\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-17, presumably until 2015-08-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-20, presumably until 2015-08-21, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-20 00:00:00, ended at 2015-08-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 08:22:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 974 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Body height: 5' 4.173\" (inch (US))\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 245 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.98 (milligram per milligram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.4 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-20, presumably until 2015-08-20\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-20, presumably until 2015-08-20\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-20, presumably until 2015-08-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-21 00:00:00, ended at 2015-08-21 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia in chronic kidney disease\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-21, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-22 00:00:00, ended at 2015-08-22 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-08-22, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) every bedtime Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-22 08:30:00, ended at 2015-08-22 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.1 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 962 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 7.47 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.24 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 65.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.63 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 55.5 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 179 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 21 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 14.62 (milligram per milligram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 74 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.9 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Body height: 5' 4.173\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 174 (microgram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 36 (microgram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n- Anemia in chronic kidney disease\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-22, presumably until 2015-08-22\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-22, presumably until 2015-08-22\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-22, presumably until 2015-08-22\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-22, presumably until 2015-09-04, with intended 11 refill(s). Instructions: inject 25 Units subcutaneous (under the skin) daily in the morning Inject 25 units under the skin every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-23 09:34:11, ended at 2015-08-23 11:50:56\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Nephrotic syndrome\n- Disorder of transplanted kidney\n- Hyperlipidemia\n- Kidney lesion\n- Anemia in chronic kidney disease\n- Secondary thrombocytopenia\n- Primary diagnosis: Membranous glomerulonephritis\n- Poisoning by drug AND/OR medicinal substance\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-24 00:00:00, ended at 2015-08-24 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nephrotic syndrome\n- Primary diagnosis: Kidney lesion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-24 12:58:00, ended at 2015-08-24 17:51:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 312 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 21.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 7.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 243 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.35 (million per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 397 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 504 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-08-24, presumably until 2015-08-24\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-24\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-24, presumably until 2015-08-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-24, presumably until 2015-08-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-24 17:52:00, ended at 2015-09-04 10:24:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Urine: 36 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 9.3 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prothrombin time (PT): 15.6 (second)\n- Tacrolimus [Mass/volume] in Blood: 9.6 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 4.15 (log international unit per milliliter)\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: 928 (international unit per milliliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.3 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 631 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 309 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Mycophenolate [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 73 (percent)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 21.25 (milligram per milligram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 17.4 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 63.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 28 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.11 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Sodium/Creatinine [Molar ratio] in Urine: 29 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.4 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 850 (picogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 3007 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 72.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Thrombin time: 18.4 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Body height: 5' 5.98\" (inch (US))\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 7.4 (milli-international unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.05 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.3 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 68.5 (nanogram per milliliter)\n- Glucose [Mass/volume] in Blood: 60 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 43 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.32 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 36.2 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.80 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.60 (micro-international unit per milliliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Potassium [Moles/volume] in 24 hour Urine: 33.9 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Plasmapheresis\n- Ultrasound, abdominal, real time with image documentation; complete\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Collection of venous blood by venipuncture\n- Hospital discharge day management; more than 30 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Occupational therapy evaluation\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Acidosis\n- Hypervolemia\n- Lymphocytosis\n- Acquired renal cystic disease\n- Acute renal failure syndrome\n- Cytomegalovirus infection\n- Nephrotic syndrome with membranous glomerulonephritis\n- Ascites\n- Gastroesophageal reflux disease\n- Kidney lesion\n- Late effect of medical and surgical care complication\n- Monoclonal gammopathy (clinical)\n- Tobacco dependence syndrome\n- Coronary arteriosclerosis\n- Pancytopenia\n- Chronic kidney disease\n- Iron deficiency anemia\n- Membranous glomerulonephritis\n- Transplanted kidney present\n- Edema\n- Hydronephrosis\n- Proteinuria\n- Secondary diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Benign hypertensive renal disease with renal failure\n- Complication due to diabetes mellitus\n- Disorder affecting transplanted structure\n- Disorder of hematopoietic structure\n- Disorder of plasma protein metabolism\n- Hyperlipidemia\n- Postprocedural state finding\n- Anemia in chronic kidney disease\n- Disorder of kidney due to diabetes mellitus\n- Disorder of transplanted kidney\n- Nephrotic syndrome\n- Renovascular hypertension\n\n### Drug\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-01\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2015-08-28, presumably until 2015-10-18, with intended 0 refill(s). Instructions: insert 1 Suppository into the rectum daily as needed\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-09-01, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 10 mL by mouth every morning with breakfast\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-03, presumably until 2015-09-04\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-06, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed for Pain or Fever\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2015-08-28, presumably until 2015-10-06, with intended 11 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) 3 times a week\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-09-04, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-08-26, presumably until 2015-09-04\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-03\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-09-04, presumably until 2015-09-04\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-08-24, presumably until 2015-08-29\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-29, presumably until 2015-09-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-08-24, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n- torsemide 20 MG Oral Tablet, through Oral route, started on 2015-08-30, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (leg edema)\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2016-09-02, with intended 0 refill(s). Instructions: inject 6 Units subcutaneous (under the skin) 3 times a day before meals\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-26, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-09-04, with intended 0 refill(s). Instructions: take 10 mg by mouth 2 times a day\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2015-08-27, presumably until 2015-08-28, with intended 0 refill(s). Instructions: take 10 g by mouth 2 times a day\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-01, presumably until 2015-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-31\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-25, presumably until 2015-10-06, with intended 0 refill(s). Instructions: inject 15 Units subcutaneous (under the skin) every bedtime\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-08-28, presumably until 2015-08-31\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-08-25, presumably until 2015-09-04\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2015-08-27, presumably until 2015-09-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday for 30 days\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-24\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2015-09-01, presumably until 2015-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-27 07:26:00, ended at 2015-08-27 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 83 (milligram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-27, presumably until 2015-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-29 07:53:00, ended at 2015-08-29 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 268 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-31 08:01:00, ended at 2015-08-31 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 91 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-08-31, presumably until 2015-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-03 08:57:00, ended at 2015-09-03 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 49 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-05 08:30:00, ended at 2015-09-05 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 1.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Body height: 5' 5.984\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 70 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 168 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2015-09-05, presumably until 2015-09-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-05, presumably until 2015-09-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-05, presumably until 2015-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-07 08:30:00, ended at 2015-09-07 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1093 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 20.90 (milligram per milligram)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 52.3 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 220 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-07, presumably until 2015-09-07\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-09-07, presumably until 2015-09-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-07, presumably until 2015-09-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-10 08:30:00, ended at 2015-09-10 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 202 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 118 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 213 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-10, presumably until 2015-09-10\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-10, presumably until 2015-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 07:30:00, ended at 2015-09-12 13:07:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 197 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 74 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 5.984\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n\n### Condition\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Nephrotic syndrome\n- Type 2 diabetes mellitus without complication\n- Hyperlipidemia\n- Kidney lesion\n- Disorder of phosphorus metabolism\n- Membranous glomerulonephritis\n- Essential hypertension\n\n### Drug\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-12, presumably until 2015-09-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-09-12, presumably until 2015-09-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-12 13:08:00, ended at 2015-09-12 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: <135 (international unit per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acquired renal cystic disease\n- Hyperlipidemia\n- Contracture of palmar fascia\n- Kidney lesion\n- Poisoning by drug AND/OR medicinal substance\n- Tobacco dependence syndrome\n- Acute renal failure syndrome\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Disorder of transplanted kidney\n- Peripheral neuritis\n- Chronic kidney disease\n- Cytomegalovirus infection\n- Gastroesophageal reflux disease\n- Membranous glomerulonephritis\n- Nephrotic syndrome\n- Secondary thrombocytopenia\n- Anemia in chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-14 09:32:00, ended at 2015-09-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-14, presumably until 2015-09-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-17 09:00:00, ended at 2015-09-17 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 93.5 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n\n### Condition\n- End-stage renal disease\n- Anemia in chronic kidney disease\n\n### Drug\n- 1 ML epoetin alfa 10000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-17, presumably until 2015-09-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-09-19 00:00:00, ended at 2015-09-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Kidney lesion\n- Membranous glomerulonephritis\n- Primary diagnosis: Nephrotic syndrome\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-10-06, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily Reduce to 10 mg daily on 10/08/2015\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 09:00:00, ended at 2015-09-19 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-09-19, presumably until 2015-09-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-20 00:00:00, ended at 2015-09-20 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-26 09:35:16, ended at 2015-09-26 10:39:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney lesion\n- Type 2 diabetes mellitus without complication\n- Anemia in chronic kidney disease\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Nephrotic syndrome\n- Cytomegalovirus infection\n- Cerebral infarction due to thrombosis of cerebral arteries\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Renovascular hypertension\n- Membranous glomerulonephritis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-26 10:44:00, ended at 2015-09-26 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.9 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 144.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 112 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 5.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Neutropenia associated with infectious disease\n- Cytomegalovirus infection\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-03 09:39:30, ended at 2015-10-03 11:52:09\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Membranous glomerulonephritis\n- Chronic kidney disease\n- Kidney disease\n- Hyperlipidemia\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n- Gastroesophageal reflux disease\n- Renovascular hypertension\n- Anemia in chronic kidney disease\n- Kidney lesion\n- Nephrotic syndrome\n- Tobacco dependence syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 13:08:00, ended at 2015-10-03 16:12:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-03, presumably until 2015-10-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-10-03 16:13:00, ended at 2015-10-06 13:29:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 486 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 182 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.08 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 87 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Urine: 85.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n\n### Procedure\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, chest; single view, frontal\n- Initial observation care, per day, for the evaluation and management of a patient which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or o\n- Hemodialysis\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n\n### Condition\n- Diabetes mellitus without complication\n- Primary diagnosis: Kidney lesion\n- Late effect of medical and surgical care complication\n- Pure hypercholesterolemia\n- Renovascular hypertension\n- Tobacco dependence syndrome\n- Lung field abnormal\n- Abnormal glucose level\n- Disorder of transplanted kidney\n- Gastroesophageal reflux disease\n- Leukocytosis\n- Membranous glomerulonephritis\n- Proteinuria\n- Transplanted kidney present\n- Disorder affecting transplanted structure\n- Disorder due to type 2 diabetes mellitus\n- Primary diagnosis: Nephrotic syndrome\n- Type 2 diabetes mellitus\n- Type 2 diabetes mellitus without complication\n- Contracture of joint of hand\n- Diabetic - poor control\n- Hyperlipidemia\n- Renal failure syndrome\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-06\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- atovaquone 150 MG/ML Oral Suspension, through Oral route, started on 2015-10-04, presumably until 2015-10-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-03, presumably until 2016-03-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-05, presumably until 2016-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-06\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-05, presumably until 2015-10-18, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed for Constipation\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-10-04, presumably until 2015-10-04\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-03\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-07-18, with intended 6 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) 3 times a day before meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2015-10-04, presumably until 2015-10-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-04, presumably until 2016-10-04, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-04, presumably until 2016-10-05, with intended 6 refill(s). Instructions: inject 20 Units subcutaneous (under the skin) every bedtime\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2015-10-04, presumably until 2015-10-04\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-06, presumably until 2015-10-06\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2015-10-03, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-17 10:41:42, ended at 2015-10-17 11:33:01\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Anemia in chronic kidney disease\n- Disorder of kidney and/or ureter\n- Renal hypertension\n- Hyperparathyroidism due to renal insufficiency\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Hyperlipidemia\n- Failed renal transplant\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- Nephrotic syndrome\n- Transplanted kidney present\n- Cerebral infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 11:47:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.25 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.6 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: >2000 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 241 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.5 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.62 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 151 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 169.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-18 12:10:29, ended at 2015-10-18 13:45:06\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Reticulocytes [#/volume] in Blood by Automated count: 130.9 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 3.42 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 857 (picogram per milliliter)\n- Body height: 5' 4.567\" (inch (US))\n- Iron [Mass/volume] in Serum or Plasma: 51 (microgram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 597.9 (nanogram per milliliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 20 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Thrombocytopenic disorder\n- Primary diagnosis: Anemia\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-10-19 00:00:00, ended at 2015-10-19 00:00:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-10-30 12:04:00, ended at 2015-11-02 16:20:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.6 (percent)\n- Protein/Creatinine [Mass Ratio] in Urine: 11.18 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- MCV [Entitic volume] by Automated count: 88.3 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 340 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 362 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1043 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 93.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.32 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Physical therapy evaluation\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of blood specimen from a completely implantable venous access device\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Radiologic examination, shoulder; complete, minimum of 2 views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Introduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, thorax, diagnostic; without contrast material\n- Performance of Urinary Filtration, Multiple (Deprecated)\n\n### Condition\n- Closed fracture of multiple ribs\n- Failed renal transplant\n- Late effect of fracture of spine AND/OR trunk without spinal cord lesion\n- Shoulder joint pain\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Essential hypertension\n- Gout\n- Renal hypertension\n- Chronic graft-versus-host disease\n- Late effect of complications of procedure\n- Transplanted kidney present\n- Atelectasis\n- Contracture of joint of hand\n- Pleural effusion\n- Renal disorder due to type 2 diabetes mellitus\n- Atrial premature complex\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Nephrotic syndrome\n- Nicotine dependence\n- Disorder of joint of shoulder region\n- End-stage renal disease\n- Hyperlipidemia\n- Hypertensive renal failure\n- Cerebral infarction\n- Primary diagnosis: Closed fracture of one rib\n- Disorder of kidney and/or ureter\n- Gastroesophageal reflux disease without esophagitis\n- Ventricular premature complex\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML influenza A virus A/California/7/2009 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Switzerland/9715293/2013 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.12 MG/ML Prefilled Syringe, through Intramuscular route, started on 2015-10-31, presumably until 2015-10-31\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-01, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 4 hours as needed\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 2 Caps by mouth daily\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily as needed (constipation)\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2017-02-21, with intended 1 refill(s). Instructions: take 20 mg by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2015-11-02\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-01, presumably until 2015-11-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: take 1 Packet by mouth daily\n- torsemide 10 MG Oral Tablet, through Oral route, started on 2015-10-07, presumably until 2016-02-27, with intended 9 refill(s). Instructions: take 10 mg by mouth 2 times a day as needed \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-31, presumably until 2015-11-02\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2015-10-30, presumably until 2015-10-30\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-10-30, presumably until 2015-11-01\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2015-10-31, presumably until 2016-02-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-10-31, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2015-10-31, presumably until 2015-11-02\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2015-10-30, presumably until 2016-02-25, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:19:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.77 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 707 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 84.1 (femtoliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 19.06 (milligram per milligram)\n- Tacrolimus [Mass/volume] in Blood: 4.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 37.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-14 09:34:44, ended at 2015-11-14 10:43:05\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.236\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia of chronic disease\n- Dupuytren's disease of palm\n- Transplanted kidney present\n- End-stage renal disease\n- Nephrotic syndrome\n- Acquired renal cystic disease\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Renal disorder due to type 2 diabetes mellitus\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-15 10:34:51, ended at 2015-11-15 11:25:08\nThe patient in this visit was 67 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Renal disorder due to type 2 diabetes mellitus\n- Contracture of joint of hand\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2015-11-15, presumably until 2015-11-15, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-14 08:58:00, ended at 2015-12-14 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- MCV [Entitic volume] by Automated count: 78.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 13.31 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.10 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.48 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.7 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 989 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 238 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 74.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 3.1 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Neutropenia associated with infectious disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-19 09:02:32, ended at 2015-12-19 09:37:10\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Chronic nephritic syndrome with membranous glomerulonephritis\n- Dupuytren's disease of palm\n- Renal hypertension\n- Anemia in chronic kidney disease\n- Hyperlipidemia\n- Chronic kidney disease\n- Disorder of kidney and/or ureter\n- Disorder of lung\n- Failed renal transplant\n- Contracture of joint of hand\n- Hyperparathyroidism due to renal insufficiency\n- Gastroesophageal reflux disease without esophagitis\n- Renal disorder due to type 2 diabetes mellitus\n- End-stage renal disease\n- Proteinuria\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-02 00:00:00, ended at 2016-01-02 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- minoxidil 2.5 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pioglitazone 30 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- rosuvastatin calcium 40 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-02, presumably until 2017-01-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-01-31 06:59:00, ended at 2016-01-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.1 (ratio)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.1 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 42.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 303 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 204 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 95 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1541 (milligram per deciliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.88 (milligram per milligram)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.3 (percent)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 155.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.72 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia associated with infectious disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-31 12:39:47, ended at 2016-01-31 15:24:19\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-14 09:30:52, ended at 2016-02-14 10:37:55\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Renal disorder due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-19 09:00:00, ended at 2016-02-19 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.6 (percent)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Urine: 129.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.89 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 1224 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 75.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 9.47 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.99 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 50.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c8ee45243a225287597a35ea571ac01271121eb2a26ab770d2c90aa6e46db81b", "prompt_hash": "914e4a1c99cc7244a7e4b744aa3724e6eb6ac0c5cc26c022ad32fce24e6fdca2", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 9, "doc": {"person_id": 115969752, "visit_occurrence_id": 108108281, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2017-09-11 00:00:00", "visit_end_datetime": "2017-09-11 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-09-11, presumably until 2017-09-11, with intended 0 refill(s). Instructions: TAKE BY MOUTH DAILY: 6TABS X5DAYS, 5TABS X2DAYS, 4TABS X2DAYS, 3TABS X2DAYS,2TABS X2DAYS, 1TAB X2DAY\n\n", "approximate_token_count": 133, "patient_first_visit_date": "2013-12-01 10:16:37", "patient_last_visit_date": "2019-12-12 00:00:00", "end_obs_date": "2018-09-11", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 13, "cumulated_visit_num": 13, "cumulated_approximate_token_count": 3388, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2013-12-01 10:16:37, ended at 2013-12-01 12:26:08\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disturbance in speech\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Multiple sclerosis\n- Abnormal urination\n- Constipation\n- Nausea and vomiting\n- Amnesia\n- Malaise\n- Hyperlipidemia\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-01 13:14:04, ended at 2014-06-01 14:57:37\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-12-29, presumably until 2016-01-24, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) 3 times a week.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- 0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-12-29, presumably until 2018-01-21, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) 3 times a week.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-07 07:43:39, ended at 2015-06-07 08:54:39\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:00:00, ended at 2015-06-07 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.02 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-24 08:03:36, ended at 2016-01-24 09:00:07\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-24 08:08:30, ended at 2016-07-24 09:01:04\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-02 08:24:00, ended at 2016-08-02 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n\n### Condition\n- Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.9 (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: 0-1 (per low powered field)\n- MCV [Entitic volume] by Automated count: 68.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 10 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field: FEW (per high power field)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 126 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 1495 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 740 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2617 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-29 09:45:13, ended at 2017-08-29 10:47:51\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of brain abnormal\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- acyclovir 800 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 800 mg by mouth daily as needed\n- diazepam 10 MG Oral Tablet, through Oral route, presumably until 2018-01-21, with intended 0 refill(s). Instructions: take 10 mg by mouth daily as needed (only takes when having seizure)\n- lisinopril 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- clonazepam 0.5 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.5 mg by mouth every day\n- gabapentin 800 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 800 mg by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-30 00:00:00, ended at 2017-08-30 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2017-08-30, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed PREDNISONE 10MG TABLET  6 Tabs (60mg) daily x 5 days = 30 Tablets.  5 Tabs (50mg) daily x 2 days = 10 Tablets.  4 Tabs (40mg) daily x 2 days =   8 Tablets.  3 Tabs (30mg) daily x 2 days =   6 Tablets.  2 Tabs (20mg) daily x 2 days =   4 Tablets.  1 Tab   (10mg) daily x 2 days =   2 Tablets.                                         Total = 60 Tablets.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-09-11, presumably until 2017-09-11, with intended 0 refill(s). Instructions: TAKE BY MOUTH DAILY: 6TABS X5DAYS, 5TABS X2DAYS, 4TABS X2DAYS, 3TABS X2DAYS,2TABS X2DAYS, 1TAB X2DAY\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-01 10:16:37, ended at 2013-12-01 12:26:08\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disturbance in speech\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Multiple sclerosis\n- Abnormal urination\n- Constipation\n- Nausea and vomiting\n- Amnesia\n- Malaise\n- Hyperlipidemia\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-01 13:14:04, ended at 2014-06-01 14:57:37\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-12-29, presumably until 2016-01-24, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) 3 times a week.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-29 00:00:00, ended at 2014-12-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- 0.5 ML interferon beta-1a 0.088 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-12-29, presumably until 2018-01-21, with intended 3 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) 3 times a week.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-07 07:43:39, ended at 2015-06-07 08:54:39\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-07 09:00:00, ended at 2015-06-07 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.96 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 72.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.02 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.61 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-01-24 08:03:36, ended at 2016-01-24 09:00:07\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-07-24 08:08:30, ended at 2016-07-24 09:01:04\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-08-02 08:24:00, ended at 2016-08-02 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n\n### Condition\n- Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-22 00:00:00, ended at 2017-08-22 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.9 (calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 21.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 340 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: 0-1 (per low powered field)\n- MCV [Entitic volume] by Automated count: 68.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 10 (cells per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- MCHC [Mass/volume] by Automated count: 30.8 (gram per deciliter)\n- Calcium oxalate crystals [#/area] in Urine sediment by Microscopy high power field: FEW (per high power field)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.79 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 126 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 1495 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 740 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2617 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-29 09:45:13, ended at 2017-08-29 10:47:51\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Imaging of brain abnormal\n- Primary diagnosis: Multiple sclerosis\n\n### Drug\n- acyclovir 800 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 800 mg by mouth daily as needed\n- diazepam 10 MG Oral Tablet, through Oral route, presumably until 2018-01-21, with intended 0 refill(s). Instructions: take 10 mg by mouth daily as needed (only takes when having seizure)\n- lisinopril 20 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- clonazepam 0.5 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.5 mg by mouth every day\n- gabapentin 800 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 800 mg by mouth 4 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-30 00:00:00, ended at 2017-08-30 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2017-08-30, presumably until 2017-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed PREDNISONE 10MG TABLET  6 Tabs (60mg) daily x 5 days = 30 Tablets.  5 Tabs (50mg) daily x 2 days = 10 Tablets.  4 Tabs (40mg) daily x 2 days =   8 Tablets.  3 Tabs (30mg) daily x 2 days =   6 Tablets.  2 Tabs (20mg) daily x 2 days =   4 Tablets.  1 Tab   (10mg) daily x 2 days =   2 Tablets.                                         Total = 60 Tablets.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 10 MG Oral Tablet, started on 2017-09-11, presumably until 2017-09-11, with intended 0 refill(s). Instructions: TAKE BY MOUTH DAILY: 6TABS X5DAYS, 5TABS X2DAYS, 4TABS X2DAYS, 3TABS X2DAYS,2TABS X2DAYS, 1TAB X2DAY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Type 2 diabetes mellitus within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of type_ii_diabetes means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a0a190abeb17bffeb8aeae7b01d7d7e74266bf0e0823f171d1aecb9c2f2de840", "prompt_hash": "27f638dbecede57f788b899fb2183997f51114233aaae0d05d0d16b8ebf017e2", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
